FCAA Resource Tracking 2008 by Funders Concerned About AIDS

E;<IJ E:<IE<; FLK 8@;J

L%J% G_`cXek_ifg`Z Jlggfik kf 8[[i\jj ?@M&8@;J `e )''.

8Zbefnc\[^\d\ekj

=:88 n`j_\j kf k_Xeb LE8@;J ]fi `kj m\ip ^\e\iflj ]le[è^ Xe[ è$bè[ jlggfik f] k_`j glYc`ZXk`fe% K_\ [XkX# Ôe[è^j# Xe[ ZfeZclj`fej gi\j\ek\[ è k_`j i\gfik Xi\ k_fj\ f] =:88 Xcfe\ Xe[ [f efk e\Z\jjXi`cp i\Õ\Zk k_\ g\ijg\Zk`m\j fi k_\ fgè`fej f] LE8@;J# fi Xep fk_\i ]le[\i% =:88 Xcjf îXk\]lccp XZbefnc\[^\j k_\ \]]fikj f] k_\ ]fccfnè^ g\fgc\ è \ejliè^ k_\ hlXc`kp Xe[ Zfdgi\_\ej`m\e\jj f] k_`j i\gfik1 ● =:88 9fXi[ d\dY\ij 8el >lgkX f] Af_ejfe Af_ejfe# DXib @j_Xl^ f] 8@;J =fle[Xk`fe f] :_`ZX^f# Xe[ A\ee`]\i BXk\j f] K_\ ?\eip A% BX`j\i =Xd`cp =fle[Xk`fe ● Afj\ 8ekfe`f @qXqfcX f] LE8@;J# Xe[ 8jki`[ 9feÔ\c[ f] k_\ <lifg\Xe ?@M&8@;J =le[\ij >iflg <=> Xe[ K_\ ;`XeX# GièZ\jj f] NXc\j D\dfi`Xc =le[ ● AXZfY >Xpc\ f] k_\ =fi[ =fle[Xk`fe =:88 k_Xebj Xcc k_\ g_`cXek_ifg`Z \ek`k`\j n_f i\jgfe[\[ kf k_\ )''. =:88 i\jfliZ\ kiXZbè^ jlim\p k_Xk gifm`[\[ k_\ Ylcb f] è]fidXk`fe ]fi k_`j glYc`ZXk`fe% K_Xebj Xcjf kf =fle[Xk`fe :\ek\i Xe[ =fle[Xk`fe J\XiZ_ ]fi lj\ f] k_\ì [XkX kf jlggc\d\ek k_`j i\gfik% =èXccp# =:88 k_Xebj Xcc k_\ ]le[è^ èjk`klk`fej k_Xk jlggfik\[ lj n`k_ X d\dY\ij_`g Zfeki`Ylk`fe è )''/ Ç fli nfib kf Yl`c[ Zfddle`kp è ?@M&8@;J g_`cXek_ifgp nflc[ efk Y\ gfjj`Yc\ n`k_flk pfli jlggfik%

L%J% G_`cXek_ifg`Z Jlggfik kf 8[[i\jj ?@M&8@;J `e )''.

KXYc\ f] :fek\ekj

2 Executive Summary 4 About FCAA and This Report 6 2008 Highlights 8 Total U.S. HIV/AIDS Grantmaking in 2007 10 Top U.S. HIV/AIDS Funders in 2007 12 Concentration of HIV/AIDS Funders 14 Changes in HIV/AIDS Grantmaking from 2005 through 2007 17 U.S. Corporate HIV/AIDS Funders 19 Geographic Distribution of HIV/AIDS Grants 30 Intended Use of HIV/AIDS Grants 31 Target Populations of HIV/AIDS Grants 32 Appendix A: Methodology 34 Appendix B: FCAA Survey 40 Appendix C: Top U.S. HIV/AIDS Funders Websites 42 Appendix D: Preliminary List of Global HIV/AIDS Funders

)

<o\Zlk`m\ JlddXip

Total HIV/AIDS-related philanthropy among U.S.-based funders increased between 2006 and 2007, continuing the trend of the last several years. Estimated HIV/AIDS-related funding disbursements by U.S.-based philanthropies grew from $504 million in 2006 to $555 million in 2007, a 10% increase. The growth in aggregate funding was primarily due to increased HIV/AIDS-related disbursements by the world’s largest private philanthropy engaged in HIV/AIDS funding, the Bill & Melinda Gates Foundation. FCAA’s annual HIV/AIDS resource tracking report of U.S. funders is based on data collected directly from funders and supplemented with information from Foundation Center, Foundation Search, and other sources. Funders were surveyed to obtain data on their HIV/AIDS-related philanthropic disbursements in 2007, including the regional distribution and intended use of funding, as well as the population groups targeted by their efforts. Key findings and highlights are as follows: ● HIV/AIDS-related philanthropic funding remained highly concentrated among a relatively small number of funders. The Gates Foundation accounted for 54% of funding disbursements in 2007. The top 10 funders, including the Gates Foundation, accounted for 79% of all HIV/AIDS-related disbursements in 2007. ● HIV/AIDS-related disbursements by corporate funders represented 18% of total funding for 2007 and 42% of all non-Gates HIV/AIDS-related philanthropy that year. ● In 2007, 80% of all disbursements were devoted to addressing the HIV/AIDS epidemic outside of the U.S. Among top funders other than the Gates Foundation, 56% of total funding disbursements were devoted to addressing HIV/AIDS outside the U.S. and the majority of funders (56%) devoted some or all of their giving to addressing the international epidemic. A significant share (46%) of funding aimed at addressing the AIDS epidemic outside the U.S. was given to organizations based in the U.S. or Canada and one-third (33%) to organizations based in Sub-Saharan Africa. ● An increased percentage of funders (45%) provided funding exclusively to address the domestic epidemic in 2007. In 2006, approximately one third (35%) of funders focused exclusively on the U.S. epidemic. As in previous years, the Northeast of the U.S. received a considerable share of all domestic funding (44%). Increased funding is needed in all regions, including in Southern states which continue to account for the greatest number of new AIDS diagnoses and the largest number of people living with AIDS. ● Regarding the intended use of HIV/AIDS-related giving, the biggest share of disbursements went to research in 2007, followed closely by HIV prevention.

=LE;<IJ :FE:<IE<; 89FLK 8@;J

● People living with HIV/AIDS (PLWHA) were identified more frequently than any other population group as chief beneficiaries of both domestic and international philanthropy by U.S.-based funders. For international funding, other population groups identified after PLWHA were, in rank order, women, youth, and orphans and vulnerable children. Domestically, population groups other than PLWHA identified were, in rank order, African-Americans, women, youth, Latinos, and gay men and men who have sex with men (MSM). It is notable that while new data from the U.S. Centers for Disease Control and Prevention indicate 53% of new HIV infections in the U.S. in 2006 were among gay men and MSM, only a third of domestic funders identified this group as a top beneficiary of their organization’s giving.

<O<:LK@ M < JLD D 8 IP

● Funder responses to the FCAA survey suggest that HIV/AIDS-related philanthropy funding levels will likely remain similar, with the potential for some increase, in 2008. Forty-one percent of funders who forecast their 2008 disbursements anticipated increases in HIV/AIDS-related funding, including two of the top ten funders. Forty-two percent of funders expect their HIV/AIDS-related disbursements to remain approximately the same or are unsure about 2008 funding levels.

Of note in this year’s report is that aggregate HIV/AIDS-related disbursements among funders other than the Gates Foundation were approximately the same in 2006 and 2007. Flat funding from one year to another may not represent a trend. Still, it is worth paying attention to levels of non-Gates funding over the coming years, particularly as demands for HIV-related services increase. Today there are more people living with HIV/AIDS in the world than ever before, HIV treatment reaches only one in three people in need, and only a minority of people have access to appropriate HIV prevention interventions. Donor investments in HIV/AIDS have shown impressive results, and scale up of HIV-related services is increasingly being recognized as an opportunity to build stronger health systems in low- and middleincome countries. Private philanthropy continues to play a critical role in the HIV/AIDS pandemic, funding services governments and other donors may be averse to supporting, testing innovative delivery models, and providing urgently needed prevention and treatment services to the millions in need.

L % J % G ? @ C 8 E K ? I F G @ : J L G G F I K K F 8 ; ; I < J J ? @ M&8 @ ; J @ E ) ' ' .

8Yflk =:88 Xe[ K_`j I\gfik

Funders Concerned About AIDS (FCAA) was founded in 1987 with the goal of mobilizing philanthropic leadership, ideas, and resources, domestically and internationally, to address the HIV/AIDS pandemic and its social and economic consequences. FCAA is the only U.S.-based organization comprised of and for private philanthropic institutions engaged in the response to HIV/AIDS. During the past 21 years, FCAA has fostered and enhanced a meaningful grantmaker response to HIV/AIDS here in the United States and abroad. In the coming year, FCAA is poised to deepen our role as a convener and connector in HIV/AIDS philanthropy. In addition to our ongoing programming to bring funders together around timely issues of importance, FCAA will hold its first-ever sector-wide annual gathering, in Washington, D.C., in September 2009. This will inaugurate a new addition to FCAA’s calendar, and each subsequent year, the annual gathering will be held in a different strategic location (in 2010 it will be held during the International AIDS Conference in Vienna), designed to provide a regular opportunity for funders to come together and engage in broad, strategic discussions about priorities and challenges in HIV/AIDS philanthropy. In order to ensure that the connections and relationships made among funders through FCAA programming are maintained and mobilized throughout the year, we have launched FCAA Connect, a funder-only intranet site. This site enables funders to search a comprehensive database to find their peers in HIV/AIDS philanthropy, and learn what others are supporting. FCAA will monitor those issues and areas of greatest interest to HIV/AIDS funders in order to design our programming to best respond to funder needs. Over the past three years, FCAA worked with the European Foundation Centre’s European HIV/AIDS Funders Group (EFG) and UNAIDS to harmonize our data collection approaches with the goal of making our data as comparable as possible, and to allow us to present the most accurate possible picture of HIV/AIDS-related philanthropy. Both FCAA and EFG have made several recent changes in the design of our surveys. These changes include tracking disbursements rather than commitments for details on funder activity, revising the definitions of the geographic regions for which we report data, and harmonizing our “intended use” categories. This year, FCAA’s and EFG’s resource tracking publications were simultaneously designed and produced, and have similar layouts. FCAA, EFG, and UNAIDS are now embarking on an effort to provide information and support to funders internationally through the creation of the Working Group on Global Philanthropic Resource Tracking. This working group is developing a list of funders globally who are engaged in funding HIV/AIDS-related programming. Our preliminary list of funders can be found in Appendix D. We welcome any information readers can provide us on other funders who should be included in this list. FCAA and EFG will be issuing a global report on HIV/AIDS philanthropy in 2009, and we want this report to be as inclusive as possible. This is FCAA’s sixth annual publication that provides data and analysis on HIV/AIDS-related philanthropic giving by U.S.-based philanthropic institutions, including private, family, and community foundations, public charities, and corporate grantmaking programs. This edition covers funding disbursements made in 2007.

=LE;<IJ :FE:<IE<; 89FLK 8@;J

All information in this report is accurate and current as of November 2008. This year’s report includes an expanded Top U.S.-Based HIV/AIDS Funders list which now includes the top 82 U.S. HIV/AIDS philanthropic entities. Each of these entities disbursed $300,000 or more to HIV/AIDS in 2007. Where possible, we have observed trends in grantmaking among these top funders.

89F LK =:88 8E ; K ? @ J I<G F IK

Some funders receive substantial funding from the U.S. government to implement HIV/AIDS programming or distribute funding to other programs. While we know these public/private partnerships are extremely valuable in ensuring that funds are allocated effectively, government funds (which are tracked and reported by UNAIDS) are not included in total grantmaking reported here because this report focuses exclusively on private sector philanthropy. See page 13 for a sidebar on public/private partnerships. As noted in Table 1, some funders reported that they received some financial resources from other agencies tracked by FCAA. At least some of these funds were used to support HIV/AIDS-related funding to other institutions. In order to avoid double counting of funds, the top grantmakers total in Table 1 reflects a reduction of $14,318,007 to correct for reported re-granting of funds from one FCAA-tracked top grantmaker to another. FCAA’s resource tracking work is intended to contribute to a critical and thoughtful assessment of the total U.S.-based philanthropic investment in HIV/AIDS. By building upon HIV/AIDS grantmaking information reported by Foundation Center and Foundation Search, and collecting other types of detailed data directly from the HIV/AIDS funders, FCAA’s goal is to create an easy-touse, comprehensive, and informative publication that captures the scope and depth of philanthropic funding and support for HIV/AIDS. FCAA hopes that this report will enable a wide variety of readers to gain new understanding about the overall distribution and diversity of U.S. HIV/AIDS philanthropic funding as well as trends in this grantmaking. We welcome input from readers about how to make future editions of U.S. Philanthropic Support to Address HIV/AIDS more useful.

L % J % G ? @ C 8 E K ? I F G @ : J L G G F I K K F 8 ; ; I < J J ? @ M&8 @ ; J @ E ) ' ' .

)''/ ?`^_c`^_kj

This report reflects data for 2007 but the events of 2008 are the context for funder decisions as we go to press. Most notable of the year’s events are the global economic crisis, presenting staggering challenges to our field, and the election of a new U.S. President, offering new opportunities for all those concerned with domestic and global health and development. This was the year the World Health Organization was finally able to announce that the primary target of its “3 by 5” Initiative had been accomplished, albeit three years later than hoped. In 2002, the agency set the goal of reaching three million people in low- and middle-income countries with antiretroviral (ARV) therapy to treat HIV/AIDS by the end of 2005. Though the world was late in reaching that target, the fact that ARV access has grown ten-fold in the last six years is a testament to the work of providers, policy makers, funders, advocates, and people living with HIV/AIDS around the world. Only a few years ago, many worried that widespread ARV delivery would be difficult or impossible to accomplish in many of the regions hardest hit by HIV/AIDS. Just recently, as part of its biennial report on the state of the global epidemic, UNAIDS delivered the welcome news that the HIV/AIDS epidemic is stabilizing in Sub-Saharan Africa and some other parts of the world. The agency was able to declare that the six-fold increase in funding for HIV prevention and treatment programming in low- and middle-income countries over the previous six years “is beginning to bear fruit, as gains in lowering the number of AIDS deaths and preventing new infections are apparent in many countries.”1 This was also the year that the international debate on the impact of rapid scale up of AIDS services on broader health systems appeared to reach its crescendo. Some prominent commentators2 argued that rapid expansion of AIDS services is weakening primary health care and distorting health systems as staff and resources are siphoned away from other health services. At the International AIDS Conference in Mexico City this summer, a series of presentations and reports detailed the positive impacts of AIDS service delivery on health systems, and many at the Conference argued that scale up of AIDS services represents a critical opportunity to strengthen health service delivery in countries around the world. These and other developments made it increasingly clear that investments in AIDS service delivery are paying off and may well be laying a foundation for broader advances in health delivery. Private philanthropy remains a critical aspect of this global response, supporting programs that governments cannot or will not fund, establishing replicable models of service delivery, and leveraging investments to bring in additional resources. Other news, however, underscored how far we still have to go in the area of prevention and that new approaches, improved policies, and increased resources are needed now more than ever. Though UNAIDS reported expanded coverage of some HIV prevention interventions, particularly prevention of mother-to-child transmission services, the significant majority of people at risk for HIV infection still do not have access to basic prevention. Revised UNAIDS estimates placed the annual rate of new HIV infections at 2.5 million, far outpacing prevention efforts and putting the attainment of universal access to AIDS treatment further away each day. 1 Joint United Nations Programme on HIV/AIDS (UNAIDS), Report on the global AIDS epidemic, Geneva, 2008 2 England, Roger. “The writing is on the wall for UNAIDS.” BMJ. May 10 2008: vol. 336

=LE;<IJ :FE:<IE<; 89FLK 8@;J

Despite the impressive mobilization around AIDS treatment delivery, as of December 2007, more than six millionâ&#x20AC;&#x201D;or two out of three peopleâ&#x20AC;&#x201D;in urgent need of ARV therapy did not have access to this treatment. There was also disappointing news from clinical trials of potential new HIV prevention technologies, including candidate vaccines and microbicides. There is hope that trials of a new ARVbased approach to HIV prevention (pre-exposure prophylaxis, or PrEP) will yield positive results in the next several years, but the clinical trials news of 2007 and 2008 reinforced the importance of bringing to scale the prevention and treatment technologies in hand today.

)''/ ?@ >?C@ >? KJ

On the domestic front, the U.S. Centers for Disease Control and Prevention (CDC) released startling new estimates indicating that annual new HIV incidence is 40% higher than previously suspected. According to the CDC figures there is a new HIV infection in the U.S. every nine minutes, a pace that has not slackened in eight years. The new data confirm earlier estimates that gay and bisexual men and African-Americans are among the groups at highest risk for HIV infection. Other studies in recent years have determined that about half of PLWHA in the U.S. are not in care and about half who meet government guidelines for initiation of ARV therapy are not receiving these lifesaving drugs. The current global economic crisis will undoubtedly result in an increased demand for philanthropic support to meet health and development needs, while at the same time putting increased strain on the resources available. FCAA will ensure that our programming in 2009 is focused on helping funders meet the challenge that is facing us. Developments in 2008, including the Presidential election in the U.S., point to important opportunities for U.S.-based philanthropic donors concerned with the HIV/AIDS epidemic. Revised epidemiological estimates on both the domestic and global levels provide new clarity about where prevention efforts need to be targeted. In addition to supporting general AIDS services, donors have a crucial role to play in promoting evidence-based policy and programming, particularly where governments are not implementing proven-effective programming or targeting services appropriately. New efforts are needed to help providers and policymakers build bridges between scale up of AIDS treatment with broader prevention delivery and strengthening of general health services. In the U.S., significant new investments are needed to address HIV incidence, particularly among populations most profoundly affected by the epidemic, and to extend the reach of care to more people in need.

L % J % G ? @ C 8 E K ? I F G @ : J L G G F I K K F 8 ; ; I < J J ? @ M&8 @ ; J @ E ) ' ' .

KfkXc L%J% ?@M&8@;J >iXekdXb`e^ `e )''.

FCAA identified 285 U.S. funders who made HIV/AIDS-related grant disbursements in 2007. These funders made 5,479 HIV/AIDS-related grant disbursements, resulting in an estimated total of $555 million in support for HIV/AIDS efforts. Note on missing data: It is important to note that despite repeated efforts, FCAA did not receive data for some funders for the years covered in this report, although we believe the great majority of grantmaking forPLWHA the top funders in 2007 has been captured here. For 2007 we did 87 not receive data from the Open Society Institute, which was a top ten funder in 2004; Coca-Cola Africa Foundation, 51 African-Americans which was a top funder in 2004, 2005, and 2006; or Brandes Family Foundation, Susan Thompson 37 Women Buffett Foundation, Gilead Foundation, Macyâ&#x20AC;&#x2122;s Foundation and Saje Foundation, which were top funders in 2005. Youth Were these data available, they 35 would likely increase the total funding numbers in 2007. Latinos

MSM

3 Chart 1a: Total IDU HIV/AIDS Grantmaking 21 Disbursements by U.S. Philanthropies 2005-2007

Other

2005

$ 356

2006

$ 504

2007

$ 555 0

100

200

300

400

500

600

HIV/AIDS Grantmaking ($ millions)

3 This chart includes all disbursement data available for all funders from 2005-2007.

=LE;<IJ :FE:<IE<; 89FLK 8@;J

FCAA asked funders about their total funding commitments in 2007, in addition to their actual disbursements. Commitments data can be useful for helping to gauge current and future outlays. (Disbursements are the amount of funding expended on grants/projects in a given year and may include funding from commitments made in prior years as well as in the current year. Commitments are funding pledged for grants/projects in a given year, whether or not the funds were disbursed in that year. For some funders, commitments and disbursements are the same in a given year; for others, commitments indicate funding above or below actual disbursements in a year.)

KFK8C L%J% ?@ M&8 @ ;J > I8EKD8B@E> @ E ) ' '.

Among the top funders tracked by FCAA, commitments decreased by nearly 50% between 2006 and 2007. This was due to particularly significant funding commitments the Gates Foundation had made in 2006 that were not repeated in 2007. Thus the decline in 2007 does not reflect an overall downward trend in funding for HIV/AIDS. PLWHA

Chart 1b: Total HIV/AIDS Grantmaking Commitments by U.S. Philanthropies 2000-2007 51 African-Americans Women

2000

$ 312

2001

$ 501

2002

$ 300

2003

$ 394

2004

$ 346

2005

$ 354

2006

$ 979 $ 491

2007 0

200

400

600

800

1000

HIV/AIDS Grantmaking Commitments ($ millions)

L % J % G ? @ C 8 E K ? I F G @ : J L G G F I K K F 8 ; ; I < J J ? @ M&8 @ ; J @ E ) ' ' .

Kfg L%J% ?@M&8@;J =le[\ij `e )''.

Eighty-two funders reported HIV/AIDS-related grantmaking disbursements of $300,000 or more in 2007. Table 1: 2007 E8D<

! LARGE PART OF ()6 #OLLABORATIVE &UND monies are included in the total figure for 4IDES &OUNDATION BUT THE #OLLABORATIVE &UND also handles funds that are not included in the Tides Foundation total. Double counting of funds is corrected in the aggregate total of disbursements.

&UNDS RECEIVED BY THE ()6 #OLLABORATIVE &UND from the U.K. Department for International Development are not included in the total as the &#!! RESOURCE TRACKING REPORT DOES NOT INCLUDE government funding.

1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28. 29. 30. 31. 32. 33. 34. 35. 36. 37. 38. 39. 40. 41. 42.

Bill & Melinda Gates Foundation, WA Abbott Laboratories Fund, IL -s!s# !)$3 &UND AND -s!s# #OSMETICS .9 4HE &ORD &OUNDATION .9 4HE "RISTOL -YERS 3QUIBB &OUNDATION )NC .9 -ERCK #OMPANY &OUNDATION AND -ERCK #O )NC .* 4HE (ENRY * +AISER &AMILY &OUNDATION #! Johnson & Johnson, NJ "ROADWAY #ARES %QUITY &IGHTS !)$3 .9 )RENE $IAMOND &UND .9 %LTON *OHN !)$3 &OUNDATION )NC #! 4HE #HILDREN S )NVESTMENT &UND &OUNDATION .9 4HE %LIZABETH 'LASER 0EDIATRIC !)$3 &OUNDATION #! 4IDES &OUNDATION #!4 4HE 2OBIN (OOD &OUNDATION .9 3ILICON 6ALLEY #OMMUNITY &OUNDATION #! .ATIONAL !)$3 &UND $# !LTRIA 'ROUP )NC .9 $ORIS $UKE #HARITABLE &OUNDATION .9 ()6 #OLLABORATIVE &UND A PROJECT OF THE 4IDES #ENTER #!5 4HE 7ILLIAM AND &LORA (EWLETT &OUNDATION #! 4HE 0lZER &OUNDATION )NC .9 4HE &OUNDATION FOR !)$3 2ESEARCH AMF!2 .9 &IRELIGHT &OUNDATION #! 2OCKEFELLER "ROTHERS &UND )NC .9 4HE 'LOBAL &UND FOR 7OMEN #! ,EVI 3TRAUSS &OUNDATION #! *OHN $ #ATHERINE 4 -AC!RTHUR &OUNDATION ), )NTERNATIONAL &UND FOR (EALTH &AMILY 0LANNING .9 4HE 7ELLS &ARGO &OUNDATION #! 3AN &RANCISCO !)$3 &OUNDATION #! 4HE .EW 9ORK #OMMUNITY 4RUST .9 !MERICAN *EWISH 7ORLD 3ERVICE )NC .9 5NITED .ATIONS &OUNDATION $# Glaser Progress Foundation, WA *AMES " 0ENDLETON #HARITABLE 4RUST 7! W. K. Kellogg Foundation, MI ( VAN !MERINGEN &OUNDATION .9 4HE 3TARR &OUNDATION .9 4HE 2OCKEFELLER &OUNDATION .9 4HE $AVID AND ,UCILE 0ACKARD &OUNDATION #! 4HE $ESIGN )NDUSTRIES &OUNDATION &IGHTING !)$3 $)&&! .9

;@J9LIJ<D<EKJ

308,917,741 26,449,721 12,490,000 1,525,000 1,450,000

:FDD@KD<EKJ

330,771,941 26,449,721 .OT AVAILABLE .OT AVAILABLE 12,490,000 .OT AVAILABLE .OT AVAILABLE .OT AVAILABLE .OT AVAILABLE .OT AVAILABLE 1,525,000 Not available .OT AVAILABLE .OT AVAILABLE

=LE;<IJ :FE:<IE<; 89FLK 8@;J

E8D<

43. 7ASHINGTON !)$3 0ARTNERSHIP $# 44. !)$3 &OUNDATION OF #HICAGO ), 45. 4HE #ALIFORNIA 7ELLNESS &OUNDATION #! 46. 4HE #OMER &OUNDATION ), 47. %XXON-OBIL &OUNDATION 48 48. Missouri Foundation for Health, MO 49. +ATE " 2EYNOLDS #HARITABLE 4RUST .# 50. 7HITE &LOWERS &OUNDATION .9 51. #HILDREN !FFECTED "Y !)$3 &OUNDATION #! 52. "ICKERSTAFF &AMILY &OUNDATION #! 53. 5NTIL 4HERE S A #URE &OUNDATION #! 54. The Annenberg Foundation, PA 55. 4HE #ALIFORNIA %NDOWMENT #! 56. 3OUTH !FRICA $EVELOPMENT &UND -! 57. "$ "ECTON $ICKINSON AND #OMPANY .* 58. 4HE *OHN 2 /ISHEI &OUNDATION .9 59. 4HE #AMPBELL &OUNDATION &, 60. The Robert Wood Johnson Foundation, NJ6 61. 0UBLIC 7ELFARE &OUNDATION )NC $# 62. Alphawood Foundation, IL 63. The George Gund Foundation, OH 64. (ARTFORD &OUNDATION FOR 0UBLIC 'IVING #4 65. The Healthcare Foundation of New Jersey, NJ 66. Indiana AIDS Fund, IN7 67. 7 - +ECK &OUNDATION #! 68. 5NITED 7AY OF .EW 9ORK #ITY .9 69. 3AN $IEGO ()6 &UNDING #OLLABORATIVE A PROJECT OF !LLIANCE (EALTHCARE &OUNDATION #! 70. 7ILLIAMSBURG #OMMUNITY (EALTH &OUNDATION 6! 71. The Kresge Foundation, MI 72. 2ICHMOND #OUNTY 3AVINGS &OUNDATION .9 73. Houston Endowment Inc., TX 74. !TLANTA !)$3 0ARTNERSHIP &UND '! 75. 4HE 'ILL &OUNDATION #/ 76. The Health Foundation of Greater Indianapolis, Inc., IN 77. Polk Bros. Foundation, IL 78. 4HE *OHN - ,LOYD &OUNDATION #! 79. !)$3 &UNDING #OLLABORATIVE /( 80. 4HE 0EW #HARITABLE 4RUSTS 0! 81. 4HE 3AN &RANCISCO &OUNDATION #! 82. 3TAYING !LIVE &OUNDATION .9 2007 HIV/AIDS Grantmaking Disbursements by Top 828 2007 HIV/AIDS Grantmaking Commitments by Top 82 Total 2007 U.S. HIV/AIDS Grantmaking Disbursements

;@J9LIJ<D<EKJ

:FDD@KD<EKJ

1,086,099 750,000 610,376 570,000 568,000 521,940 515,050

.OT AVAILABLE .OT AVAILABLE 300,000 .OT AVAILABLE .OT AVAILABLE Not available .OT AVAILABLE .OT AVAILABLE 472,958 570,000 100,000 .OT AVAILABLE Not available 515,050 .OT AVAILABLE

450,000 435,000 403,875 400,000 $540,905,580

Not available .OT AVAILABLE 575,000 403,875 400,000 $492,452,994

$554,629,404

! K_\j\ ]le[\ij i\gfik\[ k_Xk k_\p i\Z\`m\[ jfd\ Ã&#x201D;eXeZ`Xc i\jfliZ\j ]ifd fk_\i X^\eZ`\j kiXZb\[ Yp =:88% 8k c\Xjk jfd\ f] k_\j\ ]le[j n\i\ lj\[ kf jlggfik ?@M&8@;J$i\cXk\[ ]le[`e^ kf fk_\i `ejk`klk`fej% L % J % G ? @ C 8 E K ? I F G @ : J L G G F I K K F 8 ; ; I < J J ? @ M&8 @ ; J @ E ) ' ' .

6 The Robert Wood Johnson Foundation does not TYPICALLY FUND ()6 !)$3 RELATED PROJECTS 7 The Indiana AIDS Fund is a program of the Health Foundation of Greater Indianapolis, however, the two conduct separate RFPs and grantmaking. 8 To avoid double counting of funds, the Top 82 subtotal reflects a reduction of $14,318,007 to CORRECT FOR RE GRANTING OF FUNDS FROM ONE &#!! tracked top grantmaker to another. The total amount for all grantmakers reflects a reduction of $14,318,007 to account for re-granting of FUNDS FROM ONE &#!! TRACKED TOP GRANTMAKER to another.

((

:feZ\ekiXk`fe f] ?@M&8@;J =le[\ij

HIV/AIDS funding remains heavily concentrated among a relatively small number of HIV/AIDS funders. Funding disbursements from the largest U.S. HIV/AIDS grantmaker, the Bill & Melinda Gates Foundation, accounted for 54% of all identified HIV/AIDS grantmaking disbursements in 2007. The top ten U.S. HIV/AIDS funders, including the Gates Foundation, accounted for 79% of all identified HIV/AIDS grantmaking disbursements in 2007.

Chart 2: Distribution of Disbursements by Size of the U.S. HIV/AIDS Funders in 2007

Largest funder (Gates) 54% Funders (2-10) 25%

Funders (11-26) 10% Funders (27-51) 6% Funders (52-285) 5%

()

=LE;<IJ :FE:<IE<; 89FLK 8@;J

@ E : I < 8 J @ E > @ D G8 : K K ? I F L > ? G L 9 C @ : & G I @ M8K < G8 I K E < I J ? @ G J

8@;J =le[`e^ :fccXYfiXk`m\

c\m\cXe[# F_`f _Xj X _`jkfip f] c\X[\ij_`g è L%J% g_`cXek_ifgp% 8k k_\ Y\^èeè^ f] k_\ 8@;J \g`[\d`Z# K_\ >\fi^\ >le[ =fle[Xk`fe Xe[ K_\ :c\m\cXe[ =fle[Xk`fe# Yfk_ cfZXk\[ è :c\m\cXe[# n\i\ Xk k_\ ]fi\]ifek f] 8@;J ]le[è^% @k `j ef jligi`j\# k_\e# k_Xk >i\Xk\i :c\m\cXe[ nflc[ gif[lZ\ X df[\c ]fi X glYc`Z&gi`mXk\ gXike\ij_`g X[[i\jjè^ k_\ cfZXc ?@M&8@;J \g`[\d`Z% K_\ gi\Zlijfi kf kf[XpĂ&#x2039;j 8@;J =le[è^ :fccXYfiXk`m\ 8=: nXj ]fle[\[ è (0// Xj X EXk`feXc 8@;J =le[ :fddle`kp GXike\ij_`g# le[\i k_\ eXd\ f] :c\m\cXe[ :fddle`kp 8@;J GXike\ij_`g% @k nXj i\fi^Xe`q\[ kf `kj Zlii\ek jkilZkli\ Xj k_\ 8@;J =le[è^ :fccXYfiXk`m\ è (00+# n`k_ k_\ d`jj`fe kf Ă&#x2C6;jki\e^k_\e k_\ Zfddle`kpĂ&#x2039;j i\jgfej\ kf ?@M&8@;J Xj X glYc`Z&gi`mXk\ gXike\ij_`g gifm`[è^ Zffi[èXk`fe# c\X[\ij_`g# Xe[ ]le[è^ è >i\Xk\i :c\m\cXe[%Ă&#x2030; JèZ\ `kj ]fle[è^# k_\ 8=: _Xj c\m\iX^\[ Xe[ èm\jk\[ e\Xicp -%, d`cc`fe è cfZXc 8JFj Xe[ ?@M&8@;J$i\cXk\[ gifîXdj% 8=: _Xj \`^_k ]le[è^ gXike\ij# k_i\\ glYc`Z 8cZf_fc ;il^ 8[[`Zk`fe J\im`Z\j 9fXi[ f] :lpX_f^X :flekp# K_\ :`kp f] :c\m\cXe[# :lpX_f^X :flekp 9fXi[ f] :flekp :fdd`jj`fe\ij# Xe[ Ă&#x201D;m\ gi`mXk\ ]le[\ij K_\ :c\m\cXe[ =fle[Xk`fe# K_\ >\fi^\ >le[ =fle[Xk`fe# Dk% JèX` ?\Xck_ :Xi\ =fle[Xk`fe# JXèk Clb\Ă&#x2039;j =fle[Xk`fe f] :c\m\cXe[# Xe[ Le`k\[ NXp f] >i\Xk\i :c\m\cXe[ % 8cc 8=: ]le[è^ gXike\ij Xi\ i\hlì\[ Yp k_\ 8=:Ă&#x2039;j YpcXnj kf Zfeki`Ylk\ Xk c\Xjk ,'#''' kf k_\ 8=:Ă&#x2039;j gffc\[ ]le[j% Ă&#x2C6;N_\e ]le[è^ gXike\ij Zfeki`Ylk\ kf k_\ 8=:# `k `j dfi\ k_Xe X îXek#Ă&#x2030; XZZfi[è^ kf 8=: GifîXd ;ì\Zkfi CXli\\e K\nj ?XiY\ik% Ă&#x2C6;@k `j X Zfdd`kd\ek kf k_\ ]le[è^ gXike\ij_`g df[\c%Ă&#x2030; @e[\\[# \XZ_ ]le[è^ gXike\i _Xj knf i\gi\j\ekXk`m\j fe 8=:Ă&#x2039;j X[m`jfip Zfdd`kk\\# n_`Z_ `j

L % J % G ? @ C 8 E K ? I F G @ : J L G G F I K K F 8 ; ; I < J J ? @ M&8 @ ; J @ E ) ' ' .

i\jgfej`Yc\ ]fi j\kkè^ k_\ 8=:Ă&#x2039;j gi`fi`k`\j Xe[ dXbè^ ]le[è^ [\Z`j`fej% K_ifl^_ k_\ì nfib n`k_ k_\ 8=:# d\dY\ij j\\ k_\ fm\iXcc g`Zkli\ f] ?@M&8@;J Xe[ i\cXk\[ `jjl\j è efik_\Xjk F_`f% D\dY\i =iXeZ\j D`ccj jXpj k_Xk k_\ 8=: ^`m\j _\i Zfek\ok ]fi k_\ nfib k_Xk _\i fi^Xe`qXk`fe# k_\ 8cZf_fc ;il^ 8=:Ă&#x2039;j c\X[\ij_`g i\Ă&#x2022;\Zkj `kj glYc`Z&gi`mXk\ Zfdgfj`k`fe% CXK`[X C\jk\i# 8=: :_Xì# `j J\e`fi 8[[`Zk`fe J\im`Z\j GifîXd F]Ă&#x201D;Z\i Xk JXèk Clb\Ă&#x2039;j =fle[Xk`fe Xe[ ;Xm`[ D\ii`dXe# 8=:Ă&#x2039;j M`Z\$:_Xì# `j Gifa\Zk 9fXi[# Xe[ k_\ ;ì\Zkfi f] k_\ ?@M&8@;J Le`k Xk k_\ :c\m\cXe[ ;\gXikd\ek f] GlYc`Z ?\Xck_% fk_\i gXike\ij ]le[ è k_\ :c\m\cXe[ 8=:Ă&#x2039;j \ekiXeZ\ èkf k_`j Xi\eX% Xi\X% Dfjk f] k_\ ]le[è^ gXike\ij ]le[ Fe k_\ n_fc\# _fn\m\i# k_\ Y\e\Ă&#x201D;kj gifîXdj fk_\i k_Xe ?@M&8@;J# Ylk jXp f] k_\ glYc`Z&gi`mXk\ Zfdgfj`k`fe f] k_Xk k_\ì gXik`Z`gXk`fe è k_\ 8=: `j X k_\ 8=: ]Xi \oZ\\[ k_\ Z_Xcc\e^\j# Yp [\dfejkiXk`fe f] k_\ì Zfdd`kd\ek kf ]XZ`c`kXkè^ X [\î\\ f] Zffi[èXk`fe Xe[ ?@M&8@;J Xe[ b\\gj k_\d n\cc$è]fid\[% ZfccXYfiXk`fe Xdfe^ gi`mXk\ Xe[ glYc`Z CXK`[X C\jk\i# Z_Xì f] 8=:# jXpj k_Xk ]le[\ij k_Xk `j le`hl\ Xdfe^ ?@M&8@;J Y\ZXlj\ k_\ 8=: `j gifm`[è^ k\Z_e`ZXc gXike\ij_`gj% â&#x2014;? Xjj`jkXeZ\ Xe[ ZXgXZ`kp$Yl`c[è^ îXekj# k_\ ]le[è^ gXike\ij ZXe gifm`[\ fk_\i e\\[\[ jlggfik ]fi cfZXc fi^Xe`qXk`fej% @[\ek`]pè^ ]le[è^ ^Xgj Xe[ j_Xiè^ Y\jk giXZk`Z\j Xi\ d\ek`fe\[ Xj b\p \c\d\ekj f] 8=:Ă&#x2039;j jlZZ\jj Yp 9\k_ ;XidjkX[k\i f] K_\ :c\m\cXe[ =fle[Xk`fe% K_\i\ Xi\ jfd\ Z_Xcc\e^\j k_Xk Zfd\ n`k_ X glYc`Z&gi`mXk\ ]le[è^ gXike\ij_`g% =fi èjkXeZ\# glYc`Z ]le[\ij è >i\Xk\i :c\m\cXe[# c`b\ dXep è k_\ L%J%# ZXeefk jlggfik jpiè^\ \oZ_Xe^\% K_\i\]fi\# k_\ 8=: dljk Y\ ZXi\]lc efk kf lj\ `kj glYc`Z ]le[j n_\e dXbè^ îXekj ]fi k_`j Zi`k`ZXc `jjl\% 8e[ Xj k_\ 8=: \ogcfi\j `kj gfk\ek`Xc ifc\ è X[mfZXZp Xe[ gfc`Zp nfib# `kj glYc`Z&gi`mXk\ eXkli\ _Xj èkif[lZ\[ jfd\ Zfdgc`ZXk`fej k_Xk _Xm\ jcfn\[ k_\

:_Xe^\j `e ?@M&8@;J >iXekdXb`e^ ]ifd )'', k_ifl^_ )''.

Among the top 82 U.S. HIV/AIDS funders for whom FCAA had disbursement data for 2005, 2006, and 2007, 48 reported increases in HIV/AIDS grantmaking disbursements from 2005 to 2007. Thirty-eight funders reported increases from 2006 to 2007. Table 2: U.S. HIV/AIDS Funders Reporting Increases in HIV/AIDS Grantmaking Disbursements (ranked by amount of increase) EXd\ Bill & Melinda Gates Foundation, WA -s!s# !)$3 &UND AND -s!s# #OSMETICS .9 -ERCK #OMPANY &OUNDATION AND -ERCK #O )NC .* Johnson & Johnson, NJ 4HE &ORD &OUNDATION .9 Abbott Laboratories Fund, IL %LTON *OHN !)$3 &OUNDATION )NC #! 4HE #HILDREN S )NVESTMENT &UND &OUNDATION .9 The Henry J. Kaiser Family Foundation, #! 4HE 2OBIN (OOD &OUNDATION .9 !MERICAN *EWISH 7ORLD 3ERVICE )NC .9 !LTRIA 'ROUP )NC .9 &IRELIGHT &OUNDATION #! 4IDES &OUNDATION #! The William and Flora Hewlett &OUNDATION #! The David and Lucile Packard &OUNDATION #! Glaser Progress Foundation, WA International Fund for Health & Family 0LANNING .9 $ORIS $UKE #HARITABLE &OUNDATION .9 "ROADWAY #ARES %QUITY &IGHTS !)$3 .9 4HE 'LOBAL &UND FOR 7OMEN #! 4HE .EW 9ORK #OMMUNITY 4RUST .9 )RENE $IAMOND &UND .9 +ATE " 2EYNOLDS #HARITABLE 4RUST .# *OHN $ #ATHERINE 4 -AC!RTHUR Foundation, IL The Design Industries Foundation &IGHTING !)$3 $)&&! .9

)'',

)''-

)''.

:_Xe^\ )'',$'.

:_Xe^\

137,546,593

257,855,885

308,917,741

171,371,148

125%

7,812,000 23,933,226

12,925,000 19,474,610

12,490,000 26,449,721

4,678,000 2,516,495

60% 11%

550,000

1,500,000

1,525,000

975,000

177%

1,138,000

1,336,000

1,817,000

679,000

60%

=LE;<IJ :FE:<IE<; 89FLK 8@;J

EXd\ .ATIONAL !)$3 &UND $# The George Gund Foundation, OH ( VAN !MERINGEN &OUNDATION .9 4HE #OMER &OUNDATION ), "$ "ECTON $ICKINSON AND #OMPANY NJ W. K. Kellogg Foundation, MI The Robert Wood Johnson Foundation, NJ The Annenberg Foundation, PA 7ASHINGTON !)$3 0ARTNERSHIP $# 4HE #ALIFORNIA 7ELLNESS &OUNDATION #! 5NTIL 4HERE S A #URE &OUNDATION #! !)$3 &UNDING #OLLABORATIVE /(9 2OCKEFELLER "ROTHERS &UND )NC .9 #HILDREN !FFECTED "Y !)$3 &OUNDATION #! The Health Foundation of Greater Indianapolis, Inc., IN Indiana AIDS Fund, IN 4HE 7ELLS &ARGO &OUNDATION #! Polk Bros. Foundation, IL 4HE 0lZER &OUNDATION )NC .9 South Africa Development Fund, MA 4HE #AMPBELL &OUNDATION &, 5NITED .ATIONS &OUNDATION $#

)'',

)''-

)''.

:_Xe^\ )'',$'.

:_Xe^\

35,000

105,000

568,000

533,000

1523%

243,200 1,045,000

837,464 1,520,073

650,000 1,450,000

406,800 405,000

167% 39%

227,980 375,000

176,704 5,100,000

610,376 750,000

382,396 375,000

168% 100%

49,565

424,232

386,398

336,833

680%

250,000 375,550 265,000 614,041

350,000 433,900 295,000 638,455

403,875 515,050 400,000 686,828

153,875 139,500 135,000 72,787

62% 37% 51% 12%

:?8E> <J @ E ? @ M&8 @ ;J > I8EKD8B@E>

4HE !)$3 &UNDING #OLLABORATIVE UNDERTOOK a strategic planning process in 2005 that put grantmaking temporarily on hold, thus the figure for disbursements was lower that year.

L % J % G ? @ C 8 E K ? I F G @ : J L G G F I K K F 8 ; ; I < J J ? @ M&8 @ ; J @ E ) ' ' .

: ?8 E> < J @E ? @M&8 @;J >I 8 E KD 8 B @ E >

Of the top 82 funders for whom FCAA had disbursement data in 2005, 2006, and 2007, 17 reported decreases in HIV/AIDS grantmaking disbursements from 2005-2007. Twenty-seven funders reported decreases in HIV/AIDS grantmaking disbursements from 2006-2007. Table 3: U.S. HIV/AIDS Funders Reporting Decreases in HIV/AIDS Grantmaking Disbursements (ranked by amount of decrease) EXd\ 4HE 2OCKEFELLER &OUNDATION .9 The Bristol-Myers Squibb Foundation, )NC .9 "ICKERSTAFF &AMILY &OUNDATION #! The Elizabeth Glaser Pediatric AIDS &OUNDATION #! Alphawood Foundation, IL Missouri Foundation for Health, MO 4HE #ALIFORNIA %NDOWMENT #! The Foundation for AIDS Research AMF!2 .9 0UBLIC 7ELFARE &OUNDATION )NC $# 4HE 3AN &RANCISCO &OUNDATION #! ,EVI 3TRAUSS &OUNDATION #! !)$3 &OUNDATION OF #HICAGO ), 4HE 'ILL &OUNDATION #/ Houston Endowment Inc., TX Atlanta AIDS Partnership Fund, GA 4HE *OHN - ,LOYD &OUNDATION #! 4HE 0EW #HARITABLE 4RUSTS 0!

)'',

)''-

)''.

:_Xe^\ )'',$'.

:_Xe^\

1,700,600 1,667,440

2,275,000 2,147,438

570,000 1,086,099

-1,130,600 -581,341

-66% -35%

550,000 511,028

1,040,000 594,300

435,000 420,500

-115,000 -90,528

-21% -18%

)''/ =FI<:8JK

In its annual survey, FCAA asked funders about their anticipated grantmaking levels for 2008. Forty-one percent of HIV/AIDS funders (24 of the 59 who responded to this question) indicated that they expected an increase in HIV/AIDS grantmaking in 2008, including two of the ten biggest funders. Forty-two percent (25 of 59 responding) reported that they anticipate disbursements to remain at approximately the same level or were unsure, while only ten of the 59 (17%) stated they expected to see a decrease in HIV/AIDS grantmaking in 2008.

=LE;<IJ :FE:<IE<; 89FLK 8@;J

L%J% :figfiXk\ ?@M&8@;J =le[\ij

In 2007, 11 corporate foundations and giving programs were among the top 82 U.S. HIV/AIDS funders identified by FCAA. The total estimated support of these 11 entities in 2007 was $102 million (2,293 grants), representing 18% of the $555 million estimated HIV/AIDS U.S. philanthropy total for 2007, and a 3% decrease in corporate giving among the top corporate funders for whom FCAA had 2006 disbursements data.10 KXYc\ +1 Kfg L%J% :figfiXk\ ?@M&8@;J =le[\ij `e )''. Abbott Laboratories Fund, IL -s!s# !)$3 &UND AND -s!s# #OSMETICS .9 4HE "RISTOL -YERS 3QUIBB &OUNDATION )NC .9 -ERCK #OMPANY &OUNDATION AND -ERCK #O )NC .* Johnson & Johnson, NJ !LTRIA 'ROUP )NC .9 4HE 0FIZER &OUNDATION )NC .9 ,EVI 3TRAUSS &OUNDATION #! 4HE 7ELLS &ARGO &OUNDATION #! ExxonMobil Foundation, TX "$ "ECTON $ICKINSON AND #OMPANY .* Total

26,449,721 12,490,000 1,121,500 $102,228,33011

)''/ =FI<:8JK

Eight of the 11 corporate funders above provided FCAA with information about their grantmaking, including whether they expected their HIV/AIDS-related funding to increase or decrease in 2008. Two of eight said they expected funding to increase in 2008; four expected grantmaking to remain about the same. One foundation was unsure, and one foundation said it expected funding to decrease in 2008.

&#!! REPORTED MILLION IN COMMITMENTS among the top 12 corporate HIV/AIDS funders in 2006.

L % J % G ? @ C 8 E K ? I F G @ : J L G G F I K K F 8 ; ; I < J J ? @ M&8 @ ; J @ E ) ' ' .

4HIS lGURE IS ADJUSTED FOR RE GRANTING

C < M @ E > : F I G F I 8K < 8 E ; : F E J L D < I G F N < I

GIF;L:K I<;

e )''-# g_`cXek_ifg`jk 9fYYp J_i`m\i Xe[ L) ]ifekdXe 9fef# Zf$]fle[\ij f] ;8K8 ;\Yk# 8@;J# KiX[\ 8]i`ZX # lem\`c\[ I<; # X gXike\ij_`g Y\kn\\e j\m\iXc cXi^\ ZfigfiXk`fej Xe[ k_\ >cfYXc =le[ kf =`^_k 8@;J# KlY\iZlcfj`j# Xe[ DXcXi`X% I<; Ă&#x2039;j èefmXk`m\ df[\c c\m\iX^\j k_\ glYc`ZĂ&#x2039;j jg\e[è^ gfn\i kf iX`j\ dfe\p Xe[ XnXi\e\jj è k_\ Ă&#x201D;^_k X^Xèjk ?@M Xe[ 8@;J è 8]i`ZX% I<; `j efk X Z_Xi`kp# Ylk iXk_\i# XZZfi[è^ kf I<; :<F JljXe Jd`k_ <cc`j# Ă&#x2C6;Xe \Zfefd`Z è`k`Xk`m\ k_Xk X`dj kf [\c`m\i X jljkXèXYc\ Ă&#x2022;fn f] gi`mXk\ j\Zkfi dfe\p kf K_\ >cfYXc =le[%Ă&#x2030; :figfiXk`fej n_f nXek kf gXik`Z`gXk\ è I<; gXp X c`Z\ejè^ ]\\ kf Ă&#x2C6;YiXe[Ă&#x2030; j\c\Zk gif[lZkj Xj GIF;L:K I<; Xe[ Xî\\ kf j\e[ X g\iZ\ekX^\ f] k_\ gifZ\\[jĂ&#x2021;XZZfi[è^ kf I<; # Xe Xm\iX^\ f] +'$,' Ă&#x2021;[ì\Zkcp kf K_\ >cfYXc =le[% <cc`j jXpj k_Xk k_\ I<; df[\c \ejli\j `kj fne jljkXèXY`c`kp1 ZfigfiXk`fej gifĂ&#x201D;k# g\fgc\ c`mè^ n`k_ ?@M&8@;J è 8]i`ZX i\Z\`m\ m`kXc i\jfliZ\j# Xe[ Zfejld\ij gXp k_\ jXd\ gi`Z\j ]fi gif[lZkj k_\p nXek n_`c\ k_\p Y\e\Ă&#x201D;k X ^ff[ ZXlj\% N_\e I<; nXj ]fle[\[# K_\ >cfYXc =le[ i\Z\`m\[ fecp ( f] `kj ]le[è^ ]ifd ZfigfiXk`fej% Dfi\ k_Xe ((' d`cc`fe _Xj efn Y\\e [feXk\[ kf k_\ =le[ k_ifl^_ I<; Ă&#x2039;j ZfigfiXk\ gXike\ij% @e )''.# I<; nXj K_\ >cfYXc =le[Ă&#x2039;j (+k_ cXi^\jk ]le[\i% Ă&#x2C6; I<; _Xj kiXej]fid\[ gi`mXk\ j\Zkfi Zfeki`Ylk`fej ]fi k_\ >cfYXc =le[#Ă&#x2030; jX`[ ;Xm`[ <mXej# DXeX^\i f] Gi`mXk\ J\Zkfi I\jfliZ\ DfY`c`qXk`fe Xk k_\ >cfYXc =le[% 9\ZXlj\ f] `kj m`j`Y`c`kp Xe[ XkkiXZk`m\e\jj kf Zfejld\ij# <mXej Zfekèl\j# Ă&#x2C6; I<; iX`j\[ k_\ YXi ]fi fk_\i glYc`Z Xe[ gi`mXk\ j\Zkfi [fefij%Ă&#x2030; 8ZZfi[è^ kf <mXej# k_\ cXi^\jk gi`mXk\$j\Zkfi Zfeki`Ylk`fe kf k_\ =le[ gi\$ I<; nXj ( d`cc`fe# Xe[ jèZ\ I<; Y\^Xe# k_\ cXi^\jk ZfigfiXk\ ^`]k nXj *' d`cc`fe# ]ifd k_\

8 m`j`k kf X >cfYXc =le[ Xjj`jk\[ Zc`e`Z `e >_XeX

I<; dfe\p iX`j\[ ]fi k_\ >cfYXc =le[ ^f\j kf _\cg gliZ_Xj\ c`]\$jXm`e^ [il^j%

:_\mife ZfigfiXk`fe% K_\ ZXdgX`ê _Xj Xcjf _\cg\[ kf c\m\iX^\ glYc`Z$j\Zkfi [feXk`fej% Ă&#x2C6; I<; Xcjf Z_Xcc\e^\j ^fm\ied\ekj kf iX`j\ k_\ì ^Xd\#Ă&#x2030; <mXej jX`[# efkè^ k_Xk ^fm\ied\ekXc Zfeki`Ylk`fej kf k_\ =le[ _Xm\ èZi\Xj\[ jèZ\ I<; Ă&#x2039;j èZ\gk`fe% I<; _Xj Xcjf Yifl^_k dfi\ glYc`Z Xkk\ek`fe kf k_\ 8@;J \g`[\d`Z è 8]i`ZX% DXafi e\njgXg\ij# gfglcXi n\Yj`k\j# Xe[ k\c\m`j`fe j_fnj èZcl[è^ K_\ FgiX_ Nè]i\p J_fn Zfm\i\[ I<; Xe[ I<; gif[lZkj è )''- Xe[ )''.% 8ZZfi[è^ kf X YiXe[ kiXZbè^ jlim\p g\i]fid\[ ]fi I<; # ,' f] gliZ_Xj\ij n\i\ èk\i\jk\[ kf c\Xie dfi\ XYflk k_\

?@M&8@;J \g`[\d`Z% ./ f] k\\ej Xe[ e\Xicp ,' f] X[lckj Xi\ XnXi\ f] k_\ I<; YiXe[ Xe[ k_\ `jjl\ `k i\gi\j\ekj% CfZXc# eXk`feXc# Xe[ èk\ieXk`feXc fi^Xe`qXk`fej ZXe Yl`c[ f]] f] k_`j XnXi\e\jj kf dfY`c`q\ k_\ glYc`Z XYflk ?@M&8@;J `jjl\j è k_\ì fne c`m\j Xe[ Xifle[ k_\ ^cfY\% ;\jg`k\ I<; Ă&#x2039;j jlZZ\jj\j# gi`mXk\ g_`cXek_ifgp `j jk`cc m`kXc kf k_\ nfib K_\ >cfYXc =le[ [f\j% 9\ZXlj\ f] k_\ èĂ&#x2022;lo f] I<; [feXk`fej# K_\ >cfYXc =le[ `j XYc\ kf cffb ]fi dfi\ e\n îXek i\Z`g`\ekj% 8ZZfi[è^ kf <mXej# gi`mXk\ g_`cXek_ifgp ZXe lj\ `kj îXekdXbè^ i\jfliZ\j kf _\cg 8JFj iXdg lg ZXgXZ`kp Xe[ `dgifm\ giXZk`Z\j% JèZ\ K_\ >cfYXc =le[Ă&#x2039;j îXekj Xi\ g\i]fidXeZ\$YXj\[# X dfi\ fi^Xe`q\[ Xe[ m`kXc fi^Xe`qXk`feĂ&#x2021;\m\e X jdXcc fe\Ă&#x2021;ZXe lj\ gi`mXk\ îXekj kf èZi\Xj\ `kj \c`^`Y`c`kp ]fi X >cfYXc =le[ îXek% <mXej ^Xm\ Xe \oXdgc\ f] X jdXcc E>F n_`Z_ _X[ Y\\e ^`m\e X ( d`cc`fe îXek kf Y\^è X dXcXi`X gifîXd% K_`j \ogXe[\[ ZXgXZ`kp \eXYc\[ k_\ gifîXd kf \Xie X )+ d`cc`fe >cfYXc =le[ îXek%â&#x2014;?

=LE;<IJ :FE:<IE<; 89FLK 8@;J

>\f^iXg_`Z ;`jki`Ylk`fe f] ?@M&8@;J >iXekj

Among the top 82 U.S. HIV/AIDS funders in 2007, 64 (78%) provided data on the geographic distribution of their funding disbursements. FCAA gathered geographic distribution data for 17 other funders from Foundation Center, Foundation Search, grants databases on fundersâ&#x20AC;&#x2122; websites, or 990 tax forms, but could not obtain data on geographic distribution for one of the top 82 HIV/AIDS funders. Analysis by FCAA suggests that of the estimated $555 million disbursed in 2007 by the top 82 funders, at least $97.4 million was disbursed to domestic U.S. HIV/AIDS efforts, representing 18% of all HIV/AIDS grants disbursed. At least $445.7 million (80%) of HIV/AIDS grants disbursed by U.S. funders was devoted to global or international HIV/AIDS (including funds granted to U.S. organizations for international work). The remaining $12.1 million (2%) could not be characterized. Chart 3: Grant Dollar Disbursements in 2007 by Geographic Focus

International 80% Domestic 18% Uncharacterized 2%

L % J % G ? @ C 8 E K ? I F G @ : J L G G F I K K F 8 ; ; I < J J ? @ M&8 @ ; J @ E ) ' ' .

><F> I8G? @: ;@ JK I @9 L K @F E F= ? @ M&8@ ;J >I 8 E KJ

Data collected by FCAA indicates that in 2007, an increased percentage (45%) of funders provided funding exclusively to address the epidemic domestically. In 2006, 35% of those funders for whom FCAA was able to gather geographic distribution data were focused exclusively on the U.S. domestic epidemic.

Chart 4: Geographic Focus of U.S. HIV/AIDS Funders 2007

U.S. Domestic only 45%

U.S. & International 33%

International only 22%

=LE;<IJ :FE:<IE<; 89FLK 8@;J

=LE;<IJ N@K? 8 ;FD<JK@: L%J% =F:LJ

Thirty-eight of the top 82 U.S. funders in 2007 identified by FCAA disbursed 90% or more of their grantmaking to domestic HIV/AIDS issues. KXYc\ ,1 Kfg L%J% ?@M&8@;J =le[\ij n`k_ X Gi`dXi`cp ;fd\jk`Z =fZlj `e )''. "ROADWAY #ARES %QUITY &IGHTS !)$3 .9 )RENE $IAMOND &UND .9 4HE 2OBIN (OOD &OUNDATION .9 .ATIONAL !)$3 &UND $# !LTRIA 'ROUP )NC .9 4HE 0lZER &OUNDATION )NC .9 4HE 7ELLS &ARGO &OUNDATION #! 4HE .EW 9ORK #OMMUNITY 4RUST .9 *AMES " 0ENDLETON #HARITABLE 4RUST 7! ( VAN !MERINGEN &OUNDATION .9 4HE $ESIGN )NDUSTRIES &OUNDATION &IGHTING !)$3 $)&&! .9 7ASHINGTON !)$3 0ARTNERSHIP $# !)$3 &OUNDATION OF #HICAGO ), 4HE #ALIFORNIA 7ELLNESS &OUNDATION #! 4HE #OMER &OUNDATION ), Missouri Foundation for Health, MO +ATE " 2EYNOLDS #HARITABLE 4RUST .# The Annenberg Foundation, PA 4HE #ALIFORNIA %NDOWMENT #! 4HE *OHN 2 /ISHEI &OUNDATION .9 4HE #AMPBELL &OUNDATION &, Alphawood Foundation, IL The George Gund Foundation, OH (ARTFORD &OUNDATION FOR 0UBLIC 'IVING #4 The Healthcare Foundation of New Jersey, NJ Indiana AIDS Fund, IN 7 - +ECK &OUNDATION #! 5NITED 7AY OF .EW 9ORK #ITY .9 7ILLIAMSBURG #OMMUNITY (EALTH &OUNDATION 6! The Kresge Foundation, MI 2ICHMOND #OUNTY 3AVINGS &OUNDATION .9 Houston Endowment Inc., TX Atlanta AIDS Partnership Fund, GA 4HE 'ILL &OUNDATION #/ The Health Foundation of Greater Indianapolis, Inc., IN Polk Bros. Foundation, IL !)$3 &UNDING #OLLABORATIVE /( 4HE 0EW #HARITABLE 4RUSTS 0! 4HE 3AN &RANCISCO &OUNDATION #!

L % J % G ? @ C 8 E K ? I F G @ : J L G G F I K K F 8 ; ; I < J J ? @ M&8 @ ; J @ E ) ' ' .

1,086,099 750,000 570,000 568,000 521,940 515,050 450,000 435,000 420,500 403,875 400,000

100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%

)(

= LE; <I J N @K ? 8 ; F D<JK @ : L% J % =F : LJ

Chart 5 shows U.S. regional distribution of domestic HIV/AIDS philanthropic funding. Of the Top 82 funders in 2007, FCAA identified 63 who disbursed funds to addressing the U.S. domestic epidemic. FCAA was not able to determine domestic regional distribution of funding disbursements by one of these 63 funders. Approximately 1% of total grantmaking to address U.S. domestic activities tracked by FCAA was not categorized by region. The funding patterns in Chart 5 are in contrast to the epidemiology of AIDS in the U.S. According to the U.S. Centers for Disease Control and Prevention, in 2006, 40% of people living with AIDS resided in the South, a higher concentration than any other region in the country. 12 Regional Distribution of Domestic U.S. HIV/AIDS Grantmaking Funds in 2007 Chart 5: Regional Distribution of Domestic U.S. HIV/AIDS Philanthropic Funding in 2007

Northeast 44% South 20%

Midwest 11%

U.S. Territories 0% West 24% Unspecified 1%

5 3 #ENTERS FOR $ISEASE #ONTROL AND Prevention, HIV/AIDS Surveillance Report, 2006, vol. 18, Atlanta: U.S. Department of Health and (UMAN 3ERVICES #$#

))

=LE;<IJ :FE:<IE<; 89FLK 8@;J

=LE; <I J N@ K? 8 ; FD<JK @ : L%J% =F:L J

Table 6: Top Funders by U.S. Region in 2007 Efik_\Xjk )RENE $IAMOND &UND .9 -s!s# !)$3 &UND AND -s!s# #OSMETICS .9 "ROADWAY #ARES %QUITY &IGHTS !)$3 .9 4HE 2OBIN (OOD &OUNDATION .9 !LTRIA 'ROUP )NC .9 Jflk_ 4HE &ORD &OUNDATION .9 -s!s# !)$3 &UND AND -s!s# #OSMETICS .9 Abbott Laboratories Fund, IL %LTON *OHN !)$3 &OUNDATION )NC #! "ROADWAY #ARES %QUITY &IGHTS !)$3 .9 D`[n\jk Abbott Laboratories Fund, IL !)$3 &OUNDATION OF #HICAGO ), Missouri Foundation for Health, MO -s!s# !)$3 &UND AND -s!s# #OSMETICS .9 %LTON *OHN !)$3 &OUNDATION )NC #! N\jk -s!s# !)$3 &UND AND -s!s# #OSMETICS .9 -ERCK #OMPANY &OUNDATION AND -ERCK #O )NC .* Abbott Laboratories Fund, IL 3ILICON 6ALLEY #OMMUNITY &OUNDATION #! 4HE 7ELLS &ARGO &OUNDATION #!

L % J % G ? @ C 8 E K ? I F G @ : J L G G F I K K F 8 ; ; I < J J ? @ M&8 @ ; J @ E ) ' ' .

1,540,383 1,540,383 1,086,099 1,540,383

@e$B`e[ >`m`e^

i`mXk\ g_`cXek_ifg`Z fi^Xe`qXk`fej f]k\e ^`m\ dfi\ k_Xe dfe\p è k_\ i\jgfej\ kf ?@M&8@;J% =:88 f]]\ij ]le[\ij k_\ fgk`fe f] i\gfikè^ k_\ì è$bè[ ^`mè^% K_`j jXdgcè^ f] i\jgfej\j i\Ă&#x2022;\Zkj k_\ [`m\ij\ nXpj è n_`Z_ ]fle[Xk`fe Xe[ ZfigfiXk\ ]le[\ij jlggfik\[ fi^Xe`qXk`fej gifm`[è^ 8@;J$ i\cXk\[ j\im`Z\j è )''.%

â&#x2014;? 8YYfkk CXYfiXkfi`\j =le[1 ;feXk\[ )%, d`cc`fe nfik_ f] 8YYfkk gif[lZkj ]fi 9Xpcfi @ek\ieXk`feXc G\[`Xki`Z 8@;J @e`k`Xk`m\ Zcè`Z è :fejkXekX# IfdXe`X â&#x2014;? 8@;J =le[è^ :fccXYfiXk`m\1 Fi^Xe`q\[ X eXk`feXc Zfe]\i\eZ\ ]fi g\fgc\ c`mè^ n`k_ ?@M&8@;J â&#x2014;? K_\ 9i`jkfc$Dp\ij Jhl`YY =fle[Xk`fe# @eZ%1 D\[`Zè\ [feXk`fej K_ifl^_ k_\ D 8 : >ff[ Jgì`kj gifîXd# dXb\lg Xik`jkj mfclek\\i Xk cfZXc îXek\\ fi^Xe`qXk`fej kf [f dXb\fm\ij ]fi g\fgc\ c`mè^ n`k_ ?@M&8@;J% â&#x2014;?

â&#x2014;? :_`c[i\e 8]]\Zk\[ Yp 8@;J =fle[Xk`fe1 Kfpj â&#x2014;? K_\ ;\j`ê @e[ljki`\j =fle[Xk`fe =`^_kè^ 8@;J ;@==8 1 ;@==8 i\Z\`m\[ fm\i +''B è ^ff[j ]ifd [\j`ê$i\cXk\[ è[ljki`\j ]fi j`c\ek XlZk`fej â&#x2014;? Dâ&#x2014;?8â&#x2014;?: 8@;J =le[ Xe[ Dâ&#x2014;?8â&#x2014;?: :fjd\k`Zj1 K_\ >ff[ Jgì`kj ZXdgX`ê# n_`Z_ gXìj g\fgc\ c`mè^ n`k_ ?@M&8@;J n`k_ nfic[$i\efne\[ dXb\lg Xik`jkj ]fi dXb\lg k`gj Xe[ dXb\fm\ij k_Xk _\cg kf Zfm\i k_\ j`êj f] `cce\jj Xe[ Yffjk ZfeĂ&#x201D;[\eZ\2 Xe[ dXb\$lg [feXk`fej

â&#x2014;?

â&#x2014;? D\iZb :fdgXep =fle[Xk`fe Xe[ D\iZb :f%# @eZ%1 ;feXk`fe f] k_\ d\[`Zè\ JKF:I@E â&#x2014;? JkXpè^ 8c`m\ =fle[Xk`fe1 :fe[fdj# ?@M&8@;J XnXi\e\jj k\c\m`j`fe gifîXddè^ fe ;M;j# m`[\f ZXd\iXj â&#x2014;? Lek`c K_\i\Ă&#x2039;j X :li\ =fle[Xk`fe1 ;feXk`fej f] k_\ Lek`c K_\i\Ă&#x2039;j 8 :li\ YiXZ\c\k gif[lZkj kf fk_\i 8@;J fi^Xe`qXk`fejĂ&#x2039; ]le[iX`j\ij

J`cm\i YiXZ\c\kj ]ifd Lek`c K_\i\Ă&#x2039;j 8 :li\

=LE;<IJ :FE:<IE<; 89FLK 8@;J

=LE;<IJ N@K? 8 >CF98C FI @EK<IE8K@FE8C ?@M&8@;J =F:LJ

FCAA identified 22 funders out of the top 82 that disbursed 90% or more of their grantmaking to support international AIDS programming in 2007. KXYc\ .1 Kfg L%J% ?@M&8@;J =le[\ij n`k_ X Gi`dXi`cp @ek\ieXk`feXc =fZlj Bill & Melinda Gates Foundation, WA 4HE #HILDREN S )NVESTMENT &UND &OUNDATION .9 4HE 7ILLIAM AND &LORA (EWLETT &OUNDATION #! $ORIS $UKE #HARITABLE &OUNDATION .9 ()6 #OLLABORATIVE &UND A PROJECT OF THE 4IDES #ENTER #! &IRELIGHT &OUNDATION #! 2OCKEFELLER "ROTHERS &UND )NC .9 4HE 'LOBAL &UND FOR 7OMEN #! *OHN $ #ATHERINE 4 -AC!RTHUR &OUNDATION ), )NTERNATIONAL &UND FOR (EALTH &AMILY 0LANNING .9 !MERICAN *EWISH 7ORLD 3ERVICE )NC .9 Glaser Progress Foundation, WA W. K. Kellogg Foundation, MI 4HE 3TARR &OUNDATION .9 4HE 2OCKEFELLER &OUNDATION .9 4HE $AVID AND ,UCILE 0ACKARD &OUNDATION #! ExxonMobil Foundation, TX 7HITE &LOWERS &OUNDATION .9 "ICKERSTAFF &AMILY &OUNDATION #! South Africa Development Fund, MA "$ "ECTON $ICKINSON AND #OMPANY .* 3TAYING !LIVE &OUNDATION .9

L % J % G ? @ C 8 E K ? I F G @ : J L G G F I K K F 8 ; ; I < J J ? @ M&8 @ ; J @ E ) ' ' .

308,917,741 (commitments figure) 1,525,000 1,450,000 1,115,000 686,828

100% 100% 100% 99% 100%

= LE; CF 9 8 C FI @ EK< I E 8K @ F E 8 C ? @M&8 @;J =F : LJ

Of the Top 82 funders in 2007, FCAA identified 46 who disbursed funds to addressing the international epidemic. FCAA was not able to determine international regional distribution of funding disbursements by one of these 82 funders. Chart 6: Geographical Distribution of Global HIV/AIDS Philanthropic Funding in 2007

U.S. for International 45% Asia & Pacific 14% Latin America 4% Western & Central Europe 1% Eastern Europe & Central Asia 1% Caribbean 1% Canada 1% Middle East 0% North Africa 0% Sub-Saharan Africa 33%

=LE;<IJ :FE:<IE<; 89FLK 8@;J

< D G FN PF L K ? NF I C ;N @ ; <

K_\ JkXp`e^ 8c`m\ =fle[Xk`fe

_\ JkXpè^ 8c`m\ =fle[Xk`fe `j fe\ =:88Ă&#x2039;j e\n Kfg =le[\ij% E\n kf Yfk_ k_`j glYc`ZXk`fe Xe[ k_\ ]le[è^ nfic[# `kj îXekdXbè^ èZi\Xj\[ ]ifd XYflk ((+#''' è )''- kf XYflk *(/#''' è )''.% K_\ JkXpè^ 8c`m\ =fle[Xk`fe î\n flk f] DKMĂ&#x2039;j Ă&#x2C6;JkXpè^ 8c`m\Ă&#x2030; ZXdgX`ê# X pflk_$]fZlj\[ è`k`Xk`m\# jkXik\[ è (00/# n_`Z_ lj\j èefmXk`m\ d\[`X kf \[lZXk\ DKMĂ&#x2039;j Xl[`\eZ\ XYflk ?@M Xe[ 8@;J% K_\ =fle[Xk`fe Y\^Xe è )'',# n_\e >\fi^`X 8iefc[# k_\ ]fle[\i f] k_\ JkXpè^ 8c`m\ è`k`Xk`m\# nXj èjgì\[ Yp X pfle^ L^Xe[X XZk`m`jk n_f nXj ]\Xkli\[ è k_\ì [fZld\ekXip Ă&#x2C6;D\\kè^ DXe[\cX%Ă&#x2030; 8iefc[ i\Xc`q\[ _fn dlZ_ dfi\ k_`j [\[`ZXk\[ XZk`m`jk Zflc[ _Xm\ XZ_`\m\[ è _`j nfib `] _\ _X[ XZZ\jj kf \m\e jdXcc Xdflekj f] ]le[è^% K_\ JkXpè^ 8c`m\ =fle[Xk`fe jk`cc lj\j k_Xk g_`cfjfg_p è Z_ffjè^ `kj îXek\\j% K_\ =fle[Xk`fe cffbj ]fi Yfk_ è[`m`[lXc pfle^ c\X[\ij Xe[ jdXcc# è]fidXc îflgj k_Xk Zflc[ lj\ k_\ ]le[è^ kf Y\Zfd\ \jkXYc`j_\[ E>Fj% Ă&#x2C6;N\ kip kf kXb\ k_\ i`jb f] ^`mè^ k_\d X Z_XeZ\#Ă&#x2030; jXpj >iXekj DXeX^\i JXiX G`fk% JkXpè^ 8c`m\ cffbj kf ]le[ gifîXdj k_Xk Xi\ ile Yp pflk_ Xe[ X`d\[ Xk pflk_% @dgfikXekcp# k_\ DKM YiXe[ `j XkkiXZk`m\ kf pflk_# n_`Z_ ^`m\j k_\ îXek\\j Xe X[mXekX^\ è k_\ì \]]fikj kf i\XZ_ pfle^ g\fgc\ è k_\ì Zfddle`k`\j% JlZZ\jj]lc îXek\\ è`k`Xk`m\j _Xm\ èZcl[\[ X gifîXd kf \[lZXk\ pfle^ ^ìcj XYflk j\olXc`kp Xe[ XYlj\ è QXdY`X# X gifîXd kf _\cg DXjX` ki`YXc c\X[\ij \[lZXk\ k_\ì ki`Y\j XYflk ?@M&8@;J è KXeqXe`X# Xe[ X gifîXd kf _\cg è[`^\eflj g\fgc\ f] >lXk\dXcX \[lZXk\ Xifle[ ?@M&8@;J n`k_è k_\ì Zfddle`k`\j% >iXek Xdflekj _Xm\ jk\X[`cp èZi\Xj\[ Xj k_\ JkXpè^ 8c`m\ =fle[Xk`fe _Xj îfne% K_\ =fle[Xk`fe Y\^Xe ^`mè^ jdXcc îXekj Ă&#x2021; (#''' Xg`\Z\Ă&#x2021;kf gifd`jè^ pfle^ g\fgc\ Xcc fm\i k_\ nfic[%

L % J % G ? @ C 8 E K ? I F G @ : J L G G F I K K F 8 ; ; I < J J ? @ M&8 @ ; J @ E ) ' ' .

Efn# XZZfi[è^ kf G`fk# k_\ îXek\\j i\Z\`m\ Xe Xm\iX^\ f] ((#'''# Xe[# è )''.# ef dfi\ k_Xe ()#'''% <XZ_ îXek\\ `j Xcjf ^`m\e Xe è$bè[ jlggcp f] Zfe[fdj# [`jgfjXYc\ Ă&#x201D;cd ZXd\iXj# Xe[ Zfg`\j f] Xcc k_\ JkXpè^ 8c`m\ ZXdgX`ê Ă&#x201D;cd dXk\i`Xcj% @e )''.# îXek\\j Xcjf Y\^Xe i\Z\`mè^ m`[\f ZXd\iXj kf [fZld\ek Xe[ glYc`Z`q\ k_\ì fi^Xe`qXk`fe è fi[\i kf lck`dXk\cp _\cg k_\d j\Zli\ ]le[è^ ]ifd fk_\i fi^Xe`qXk`fej% K_`j p\Xi# îXek\\j Y\^Xe i\Z\`mè^ X ,'' k\Z_efcf^p jk`g\e[# n_`Z_ dXep jk`cc lj\ kf gliZ_Xj\ m`[\f ZXd\iXj# Ylk jfd\ lj\ kf Ylp Zfdglk\ij# jf]knXi\# fi k\c\m`j`fej% K_\ dXafi`kp f] k_\ JkXpè^ 8c`m\ =fle[Xk`feĂ&#x2039;j ]le[è^ `j iX`j\[ k_ifl^_ `kj gXike\i# K_\ 9f[p J_fg# X ^cfYXc i\kX`c Zfjd\k`Zj ZfdgXep% JèZ\ )''.# K_\ 9f[p J_fg _Xj XeelXccp Zi\Xk\[ X c`d`k\[ \[`k`fe gif[lZk kf j\cc è jlggfik f] k_\ =fle[Xk`fe# n`k_ ('' f] k_\ gifZ\\[j ]ifd k_\ jXc\ f] k_Xk gif[lZk ^fè^ kf k_\ JkXpè^ 8c`m\ =fle[Xk`fe% 8[[`k`feXccp# DKM e\knfibj gifm`[\j f]Ă&#x201D;Z\ jgXZ\ Xe[ _Xj jfd\ f] k_\ jkX]] fe `kj gXpifcc# n_`Z_ Zfm\ij k_\ dXafi`kp f] k_\ fg\iXkè^ Zfjkj f] k_\ JkXpè^ 8c`m\ =fle[Xk`fe# Xe[

JkXp`e^ 8c`m\ =fle[Xk`fe 8dYXjjX[fi B\ccp IfncXe[ gi\j\ekj X ^iXek kf <c`qX ]ifd KXeqXe`X%

\ejli\j k_Xk dfjk f] k_\ dfe\p iX`j\[ `j i\j\im\[ ]fi îXek\\j% K_\ =fle[Xk`fe _Xj dX[\ jlYjkXek`Xc Z_Xe^\j è )''/ kf i\Ă&#x2022;\Zk `kj Zfdd`kd\ek kf jljkXèXY`c`kp% >iXek\\j Xi\ efn gXì\[ n`k_ X Zfddle`kp d\ekfi n_f _\cgj ^l`[\ k_\d k_ifl^_ cfZXc èjk`klk`fej# Xe[ n_fj\ Zfee\Zk`fej Zflc[ X`[ X eXjZ\ek fi^Xe`qXk`fe% K_`j p\Xi# îXek\\j _Xm\ Xcjf Y\^le kXbè^ X jg\Z`Xccp [\j`ê\[ Zflij\ k_Xk n`cc ]fZlj fe ZXgXZ`kp Yl`c[è^# Xe[ èZcl[\ kiXèè^ fe ]le[iX`jè^# dfe`kfiè^ Xe[ \mXclXk`fe# k\Z_e`ZXc ZXgXZ`kp Xe[ d\[`X kiXèè^% CXjkcp# îXek\\j n_f _Xm\ X jlZZ\jj]lc Ă&#x201D;ijk p\Xi Xi\ èm`k\[ kf Xggcp ]fi *$p\Xi ]le[è^ n`k_ k_\ =fle[Xk`fe% Ă&#x2C6;N\ Y\c`\m\ k_Xk `kĂ&#x2039;j gXik f] k_\ JkXpè^ 8c`m\ =fle[Xk`feĂ&#x2039;j i\d`k kf _\cg fli îXek\\j Y\ jljkXèXYc\# jf \m\ipk_è^ k_Xk n\ [f# flkj`[\ f] k_\ ZXj_ îXek# `j Yl`ck kfnXi[j k_Xk#Ă&#x2030; G`fk jXpj% Ă&#x2C6;K_\ X`d `j k_Xk n_\e n\ _Xm\ kf jkfg Ă&#x201D;eXeZ`Xccp jlggfikè^ fli îXek\\j# n\ _Xm\ [fe\ Xj dlZ_ Xj gfjj`Yc\ kf _\cg jljkXè k_\d ^fè^ ]finXi[%Ă&#x2030; â&#x2014;?

><F > I 8G? @: ; @ JK I @ 9 L K @ F E F = ?@ M&8@ ;J > I 8 E KJ

Table 8: Focus of Funding by the Top 82 U.S. HIV/AIDS Funders in 2007 (in alphabetical order)

Abbott Laboratories Fund, IL !)$3 &OUNDATION OF #HICAGO ), !)$3 &UNDING #OLLABORATIVE /( Alphawood Foundation, IL !LTRIA 'ROUP )NC .9 !MERICAN *EWISH 7ORLD 3ERVICE )NC .9 The Annenberg Foundation, PA Atlanta AIDS Partnership Fund, GA "$ "ECTON $ICKINSON AND #OMPANY .* "ICKERSTAFF &AMILY &OUNDATION #! 4HE "RISTOL -YERS 3QUIBB &OUNDATION )NC .9 "ROADWAY #ARES %QUITY &IGHTS !)$3 .9 4HE #ALIFORNIA %NDOWMENT #! 4HE #ALIFORNIA 7ELLNESS &OUNDATION #! 4HE #AMPBELL &OUNDATION &, #HILDREN !FFECTED "Y !)$3 &OUNDATION #! 4HE #HILDREN S )NVESTMENT &UND &OUNDATION .9 4HE #OMER &OUNDATION ), 4HE $ESIGN )NDUSTRIES &OUNDATION &IGHTING !)$3 $)&&! .9 $ORIS $UKE #HARITABLE &OUNDATION .9 4HE %LIZABETH 'LASER 0EDIATRIC !)$3 &OUNDATION #! %LTON *OHN !)$3 &OUNDATION )NC #! ExxonMobil Foundation, TX &IRELIGHT &OUNDATION #! 4HE &ORD &OUNDATION .9 4HE &OUNDATION FOR !)$3 2ESEARCH AMF!2 .9 Bill & Melinda Gates Foundation, WA 4HE 'ILL &OUNDATION #/ Glaser Progress Foundation, WA 4HE 'LOBAL &UND FOR 7OMEN #! The George Gund Foundation, OH (ARTFORD &OUNDATION FOR 0UBLIC 'IVING #4 The Health Foundation of Greater Indianapolis, Inc., IN The Healthcare Foundation of New Jersey, NJ 4HE 7ILLIAM AND &LORA (EWLETT &OUNDATION #! ()6 #OLLABORATIVE &UND A PROJECT OF THE 4IDES #ENTER #! Houston Endowment Inc., TX Indiana AIDS Fund, IN )NTERNATIONAL &UND FOR (EALTH &AMILY 0LANNING .9 )RENE $IAMOND &UND .9 *AMES " 0ENDLETON #HARITABLE 4RUST 7! Johnson & Johnson, NJ

;fd\jk`Z

@ek\ieXk`feXc

9fk_ â&#x2014;?

â&#x2014;? â&#x2014;? â&#x2014;? â&#x2014;? â&#x2014;? â&#x2014;? â&#x2014;? â&#x2014;? â&#x2014;?

â&#x2014;?

â&#x2014;? â&#x2014;? â&#x2014;?

â&#x2014;? â&#x2014;?

â&#x2014;? â&#x2014;? â&#x2014;? â&#x2014;? â&#x2014;?

â&#x2014;? â&#x2014;? â&#x2014;? â&#x2014;? â&#x2014;? â&#x2014;? â&#x2014;? â&#x2014;? â&#x2014;?

â&#x2014;? â&#x2014;?

â&#x2014;?

=LE;<IJ :FE:<IE<; 89FLK 8@;J

><F >I8G?@ : ;@ JK I @ 9 L K @ F E F= ?@ M&8@ ;J > I8 E KJ

Table 8: Focus of Funding by the Top 82 U.S. HIV/AIDS Funders in 2007 (in alphabetical order) (continued)

The Robert Wood Johnson Foundation, NJ 7 - +ECK &OUNDATION #! W. K. Kellogg Foundation, MI The Kresge Foundation, MI ,EVI 3TRAUSS &OUNDATION #! 4HE *OHN - ,LOYD &OUNDATION #! -s!s# !)$3 &UND AND -s!s# #OSMETICS .9 *OHN $ #ATHERINE 4 -AC!RTHUR &OUNDATION ), -ERCK #OMPANY &OUNDATION AND -ERCK #O )NC .* Missouri Foundation for Health, MO .ATIONAL !)$3 &UND $# 4HE .EW 9ORK #OMMUNITY 4RUST .9 4HE *OHN 2 /ISHEI &OUNDATION .9 4HE $AVID AND ,UCILE 0ACKARD &OUNDATION #! 4HE 0EW #HARITABLE 4RUSTS 0! 4HE 0FIZER &OUNDATION )NC .9 Polk Bros. Foundation, IL 0UBLIC 7ELFARE &OUNDATION )NC $# +ATE " 2EYNOLDS #HARITABLE 4RUST .# 2ICHMOND #OUNTY 3AVINGS &OUNDATION .9 2OBIN (OOD &OUNDATION .9 4HE 2OCKEFELLER "ROTHERS &UND )NC .9 4HE 2OCKEFELLER &OUNDATION .9 3AN $IEGO ()6 &UNDING #OLLABORATIVE A PROJECT OF !LLIANCE (EALTHCARE &OUNDATION #! 3AN &RANCISCO !)$3 &OUNDATION #! 4HE 3AN &RANCISCO &OUNDATION #! 3ILICON 6ALLEY #OMMUNITY &OUNDATION #! South Africa Development Fund, MA 4HE 3TARR &OUNDATION .9 3TAYING !LIVE &OUNDATION .9 4IDES &OUNDATION #! 5NITED .ATIONS &OUNDATION $# 5NITED 7AY OF .EW 9ORK #ITY .9 5NTIL 4HERE S A #URE &OUNDATION #! ( VAN !MERINGEN &OUNDATION .9 7ASHINGTON !)$3 0ARTNERSHIP $# 4HE 7ELLS &ARGO &OUNDATION #! 7HITE &LOWERS &OUNDATION .9 7ILLIAMSBURG #OMMUNITY (EALTH &OUNDATION 6!

L % J % G ? @ C 8 E K ? I F G @ : J L G G F I K K F 8 ; ; I < J J ? @ M&8 @ ; J @ E ) ' ' .

;fd\jk`Z

@ek\ieXk`feXc

9fk_ ●

● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●

● ● ● ● ●

●

● ●

●

● ● ●

●

@ek\e[\[ Lj\ f] ?@M&8@;J >iXekj

Among the top 82 U.S. HIV/AIDS funders in 2007, 63 (77%) provided survey data on intended use of their HIV/AIDS grants. &#!! WAS ABLE TO GATHER INTENDED USE DATA FOR ADDITIONAL FUNDERS FROM &OUNDATION #ENTER &OUNDATION 3EARCH GRANTS PLWHA 87 DATABASES ON FUNDERS WEBSITES OR TAX FORMS BUT COULD NOT OBTAIN INTENDED USE DATA FOR TWO OF THE TOP ()6 !)$3 African-Americans 51 funders.

Women 37 Chart 7: Intended Use of U.S. HIV/AIDS Grantmaking in 2007 Youth 35 Latinos

Prevention

$150,722,358

Treatment

$93,789,301

Social Services

$40,355,526

Advocacy

$60,881,614

Research

$179,230,467

Other

$31,657,590 $0

$50,000,000

$100,000,000

$150,000,000

$200,000,000

The â&#x20AC;&#x153;Otherâ&#x20AC;? category includes funds from organizations that did not disaggregate data based on intended use, funding that WAS UN SPECIlED OR FUNDING FOR PROJECTS THAT DID NOT FALL UNDER OUR CATEGORIES SUCH AS CARE AND TREATMENT FOR CHILDREN orphaned by AIDS, capacity-building, fundraising events, and general support.

=LE;<IJ :FE:<IE<; 89FLK 8@;J

KXi^\k GfglcXk`fej f] ?@M&8@;J >iXekj

Among the top 82 U.S. HIV/AIDS funders in 2007, 63 domestic and 45 international funders identified the three population groups that receive the greatest benefit from their domestic and international funding.

Chart 8: Target Populations for U.S. HIV/AIDS Grantmaking in 2007 Domestic Funding Target Populations PLWHA

87%

African-Americans

51%

Women

37%

Youth

35%

Latinos

33%

MSM

32%

IDU

21%

Other

13%

HCW

10%

Asian/Pacific Islanders

OVC

8% 0

Pecentage of Top Funders

PLWHA International Funding Target Populations African-Americans

100

100%

PLWHA 69%

Women 53%

Youth 27%

OVC 20%

MSM

18%

HCW SW

16%

IDU

16%

Other

16% 0

Pecentage of Top Funders

L % J % G ? @ C 8 E K ? I F G @ : J L G G F I K K F 8 ; ; I < J J ? @ M&8 @ ; J @ E ) ' ' .

100

HCW: Health care workers IDU: )NJECTING DRUG USERS MSM: Men who have sex with men OVC: Orphaned/vulnerable children PLWHA: People living with HIV/AIDS SW: Sex workers

8gg\e[`o 81 D\k_f[fcf^p

FCAA is an active partner in the UNAIDS Global Consortium on Resource Tracking in efforts to track and better understand resource flows addressing HIV/AIDS issues and define consistent and transparent HIV/AIDS resource tracking methodologies. JFLI:<J F= ?@M&8@;J >I8EKD8B@E> ;8K8

This report covers HIV/AIDS grant disbursements from all sectors of U.S. philanthropy, including private, family, and community foundations, public charities, corporate grantmaking programs (corporate foundations and direct giving programs), and major U.S. HIV/AIDS grantmaking charities. FCAA included data for over 280 grantmaking organizations in this report. Data were collected using a variety of sources: 1) a survey tool developed and administered by FCAA to funders, 2) Foundation Centerâ&#x20AC;&#x2122;s and Foundation Searchâ&#x20AC;&#x2122;s grants databases, and 3) funder websites, 990 forms, and other philanthropy affinity groups and research organizations. FCAA believes that this multifaceted approach arrives at a more comprehensive data set of HIV/AIDS funders than can be accomplished using any single data source or any single method of calculation. =:88 =LE;<I JLIM<P

FCAA distributed a survey instrument that asked *)

respondents to describe their HIV/AIDS-related grantmaking disbursements in 2007 (see Appendix B). The survey was sent to several hundred U.S. funders in June 2008. FCAA staff distributed the survey to a pre-selected list of grantmaking organizations which FCAA determined were most likely to have significant levels of 2007 HIV/AIDS grantmaking and/or were most likely to list HIV/AIDS as a priority funding issue. Staff conducted several rounds of follow-up to secure as much data as possible directly from funders.

Society Institute, the Susan Thompson Buffett Foundation, Macyâ&#x20AC;&#x2122;s Foundation, CocaCola Africa Foundation, Brandes Family Foundation, Gilead Foundation, and Saje Foundation (all likely to be top HIV/AIDS funders) were not available, and therefore not included, at the time of publication of this report. 8E8CPJ@J ;<=@E@K@FE F= ?@M&8@;J G?@C8EK?IFGP

=FLE;8K@FE :<EK<I 8E; =FLE;8K@FE J<8I:? ;8K898J<J 8E; FK?<I JFLI:<J

FCAA was intentionally broad in its definition and selection of U.S. HIV/AIDS funders by including the HIV/AIDS philanthropic activity of several large U.S.-based public charities, donor-advised funds, corporate grantmaking programs, and operating foundations. While this report focuses only on U.S.-based funders, it also includes HIV/AIDS grants from the non-U.S. offices of U.S.-based foundations that operate internationally, such as the Ford Foundation.

To capture data for which FCAA did not have survey responses, FCAA conducted further research of U.S. HIV/AIDS funders and 2007 HIV/AIDS grant disbursements using Foundation Center and Foundation Search grants databases, as well as grantmaker websites. FCAA reviewed HIV/AIDS grantmaking totals and notable dataset outliers. It is important to reiterate that 2007 data for the Open

Survey respondents were asked to distinguish between domestic (within the U.S. and for U.S. programs) and international HIV/AIDS efforts, to the extent possible. For domestic U.S. grantmaking, FCAA requested regional data based on five U.S. sub-regions, using Northeast, South, Midwest, West, and U.S. Territories categories as defined by the U.S. Census Bureau and used by the U.S.

Responses to the survey were received from 93 funders, either through fully completed surveys or other communications with foundation staff. Over 94% of estimated total HIV/AIDS grantmaking activity is captured by surveys returned to FCAA.

Centers for Disease Control and Prevention (CDC) and other federal agencies.13 For internationally focused HIV/AIDS grantmaking, FCAA requested data about where the grantee was located, using global regions as defined by UNAIDS.14 FCAA also asked about the intended use of HIV/AIDS grants disbursed in both inside and outside the United States, using the following six categories: â&#x2014;? HIV/AIDS awareness and prevention (including harm reduction) â&#x2014;? HIV/AIDS-related treatment and medical care (including provider and patient treatment information) â&#x2014;? HIV/AIDS-related social services (e.g. housing, employment, food, legal) â&#x2014;? HIV/AIDS public policy, advocacy and communication â&#x2014;? HIV/AIDS research (including medical, prevention, and social science research), and â&#x2014;? Other

This year for the first time, FCAA asked funders to identify the three population groups that benefited the most from their domestic and/or international funding. The tally 5 3 #ENSUS "UREAU h#ENSUS 2EGIONS AND Divisions of the United States:â&#x20AC;? www.census.gov

www.unaids.org =LE;<IJ :FE:<IE<; 89FLK 8@;J

of responses provided here captures the number of funders focusing on particular groups, not the relative share of actual funding dedicated to addressing these groups. ;@J9LIJ<D<EKJ MJ% :FDD@KD<EKJ

This year FCAA uses fundersâ&#x20AC;&#x2122; disbursements rather than funding commitments to calculate distribution of total funding by geographic region, intended use and other details. The reliance on disbursement data for funding details harmonizes our report with other resource tracking projects. Because of this change to tracking disbursement rather than commitment details, it is difficult to make exact comparisons between data in this yearâ&#x20AC;&#x2122;s report and previous FCAA resource tracking reports. :8C:LC8K@FEJ F= FK? <==FIKJ

In some cases, the HIV/AIDS philanthropy reported to FCAA includes the value of programmatic efforts and operational grantmaking. For example, the Henry J. Kaiser Family Foundation is primarily an operating foundation, not a grantmaking foundation, and its reported efforts include 2007 disbursements to HIV/AIDS policy, communications, and media education and campaigns (including, for example, funding for its HIV/AIDS webcasts and Daily HIV/AIDS

report), but not operational (internal) staff or other costs. :8C:LC8K@FEJ F= I<$>I8EK@E>

To avoid counting the same funds twice, data in this report are adjusted to account for known re-granting. Re-granting refers to funds given by one FCAA-tracked grantmaker to another for the purposes of making HIV/AIDS-related grants. The 2007 aggregate total grantmaking for all funders was adjusted downward by $14,468,007 to account for known re-granting. This adjustment represents approximately 3% of the total estimated 2007 HIV/AIDS grant disbursements. The re-granting figures are estimates based on direct communications with funders following review of FCAA survey and Foundation Center and Foundation Search data. The true re-granting total is likely modestly higher than the total used for calculating the 2007 total. C@D@K8K@FEJ

FCAAâ&#x20AC;&#x2122;s data may differ from other data on HIV/AIDS philanthropy in several ways: 1) Although the use of multiple data sources safeguards the accuracy of the information presented here, such reliance also presents challenges in reconciling the different methodologies (each of which has its respective advantages and limitations)

L % J % G ? @ C 8 E K ? I F G @ : J L G G F I K K F 8 ; ; I < J J ? @ M&8 @ ; J @ E ) ' ' .

applied to obtain information about grantmaking and philanthropic support activity. 2) Missing data/underreporting: FCAA recognizes that its data for 2007 HIV/AIDS grantmaking are likely to have missed HIV/AIDS disbursements from some institutions for which FCAA had no information or incomplete or unverified data. FCAA was also unable to collect data from some of the philanthropic organizations that did not respond to the survey, in addition to institutions for which data were unavailable from Foundation Center, Foundation Search, or other sources. In the case of corporations, while federal law makes a corporationâ&#x20AC;&#x2122;s tax returns open to the public, businesses are not otherwise legally required to disclose details about corporate philanthropic giving, thus making measurement of corporate philanthropic efforts even more challenging than estimations of private foundation/public charity giving. Adding to the special nature of such calculations, corporations are neither required nor always able to place a value on the many forms of other support they can and do offer, such as volunteer efforts by their employees, in-kind donations, cause-related marketing, and similar activities.15 Finally,

philanthropic support is often not collected centrally within business organizations and may be higher than reported here. 16 3) The definition of HIV/AIDS-related philanthropy in the survey was intentionally inclusive and broad, acknowledging that such efforts often overlap with many other issue areas of philanthropy. Several respondents chose a restricted definition and reporting of HIV/AIDS-related grantmaking, excluding grants that were not wholly focused on HIV/AIDS efforts.

3EE ALSO #OMMITTEE TO %NCOURAGE #ORPORATE 0HILANTHROPY h4HE #ORPORATE 'IVING 3TANDARD ! -EASUREMENT -ODEL FOR #ORPORATE 0HILANTHROPY v which aims to establish methods of accounting for corporate contributions: www.corphilanthropy. org.

!CCORDING TO THE .ATIONAL #OMMITTEE FOR Responsive Philanthropy, an estimated 50% of corporate philanthropy is undisclosed to THE !MERICAN PUBLIC .ATIONAL #OMMITTEE FOR 2ESPONSIVE 0HILANTHROPY 4HE .#20 1UARTERLY Summer 2003. p 7.

8gg\e[`o 91 =:88 )''. ?@M&8@;J I\jfliZ\ KiXZb`e^ Jlim\p

eXd\ f] fi^Xe`qXk`fe1 g\ijfe Zfdgc\k`e^ jlim\p1 \$dX`c X[[i\jj1 k\c\g_fe\1 fi^Xe`qXk`fe n\Yj`k\ lic1

In answering the questions below, please note the following: ■

Change #1 in this year’s survey: Starting this year, questions about the geographic focus and intended use of funding are asked about your organization’s disbursements. In previous years we asked these detailed questions about commitments rather than disbursements. As with last year, we are asking you to report total HIV/AIDS-related disbursements and commitments; but this year the more detailed questions concern disbursements. We are making this change to harmonize our report with other resource tracking efforts, and we also believe that details on disbursements will be more relevant to policy makers, funders, and advocates. If you are unable to answer any of the survey questions for your disbursements, but could provide data based on commitments, please provide that data with a note that the data was based on commitments. Disbursements: Disbursements are the amount of funding expended on grants/projects in a given year and may include funding from commitments made in prior years as well as in the current year. Commitments: Commitments are funding pledged for grants/projects in a given year, whether or not the funds were disbursed in that year

■

Change #2 in this year’s survey: This year we have added a question that asks you to identify the top three targeted populations your organization aims to reach. This information will only be reported in aggregate (not by individual funder) in our resource tracking publication.

■

Defining an HIV/AIDS grant or project: In addition to reporting on grants/projects that are focused explicitly on HIV/AIDS, please include grants/projects made in other health, social, economic, and political areas when a significant aspect of the grant or project included a focus on HIV/AIDS.

■

Activities to include: Please restrict your answers to external HIV/AIDS grantmaking/projects (i.e. do not count internal expenditures on staff and/or other programming). Private Operating Foundations (as defined by IRS, any private foundation that spends at least 85% of its adjusted net income or its minimum investment return, whichever is less, directly for the active conduct of its exempt activities) should include the direct costs of HIV/AIDS-related programs only and not costs for staff. Do not include the value of donated services, products, or other in-kind donations. (there is a space to list examples of your organization’s in-kind donations, if you wish) Do not include grants/projects committed or disbursed from funding received from the U.S. or any government.

Please complete the survey by June 30, 2008. Return your completed survey to Chris Collins via e-mail at ChrisCSF@aol.com or fax at (530) 380.3822. *+

=LE;<IJ :FE:<IE<; 89FLK 8@;J

HL<JK@FEJ =FI )''.

1a. What was the total dollar amount of your HIV/AIDS grant/project disbursements in 2007?

$ _______________________

Note: Disbursements means the total dollar amount actually paid out to grantees/projects or for projects during the calendar year. This total should include funds re-granted from other organizations.

1b. What was the total dollar amount of your HIV/AIDS grant/project commitments in 2007?

$ _______________________

Note: Commitments means the total dollar amount pledged during the calendar year, whether the funds were disbursed in that or another year. This total should include funds re-granted from other organizations. A multi-year grant/project should be fully counted in the year that it was committed.

All subsequent questions for this year refer to grant/project disbursements only. (Private Operating Foundations should include only the direct costs of HIV/AIDS-related programs) 1c. Private Operating Foundations only: Of the amount reported in #1a above, please provide a breakdown between: The dollar amount of HIV/AIDS cash grants disbursed in 2007

$ _______________________

The dollar value of HIV/AIDS program activities conducted in 2007

$ _______________________

1d. All organizations: Compared to 2007, please predict whether the total amount of your HIV/AIDS disbursements in 2008 will (please type ‘x’ by only one response): increase decrease remain the same discontinue unsure

___ ___ ___ ___ ___

2. What was the total number of HIV/AIDS grants/projects disbursed in 2007? 2a. Were any of these grants/projects multi-year commitments?

Y [ ] / N [ ]

_______________________ (type ‘x’ next to one)

3. In 2007, where were your HIV/AIDS grant/project dollars disbursed? (Please approximate total dollar amounts as best you can for the locations of grant recipients/projects. The geographical location would be where the recipient’s main office is situated. If you are unable to provide geographical data on disbursements, but could provide data based on commitments, please provide the data with a note that the data was based on commitments.) The amounts in 3a, 3b, and 3c should add up to the total reported for question 1a.

L % J % G ? @ C 8 E K ? I F G @ : J L G G F I K K F 8 ; ; I < J J ? @ M&8 @ ; J @ E ) ' ' .

3a. Total dollars disbursed to U.S.-based grantees/projects for domestic HIV/AIDS programs:

$_______________________

Please provide total dollar disbursements by region (the definitions of U.S. regions are consistent with U.S. Census definitions): Amounts should add up to the total reported for question 3a. Northeast South Midwest West U.S. territories

$ __________ (CT, MA, ME, NH, NJ, NY, PA, RI, VT) $ __________ (AL, AR, DC, DE, FL, GA, KY, LA, MD, MS, NC, OK, SC, TN, TX, VA, WV) $ __________ (IA, IL, IN, KS, MI, MN, MO, NE, ND, OH, SD, WI) $ __________ (AK, AZ, CA, CO, HI, ID, MT, NV, NM, OR, UT, WA, WY) $ __________ (PR, VI)

3b. Total dollars disbursed to U.S.-based grantees/projects for international HIV/AIDS work: : 3c. Total dollars disbursed to grantees/projects based outside the United States for international HIV/AIDS work:

$ _______________________

Please provide total dollar disbursements to grantees/projects by region. Please see Appendix 1 for definition of each region. The amounts here should add up to the total reported for question 3c Canada Caribbean Latin America Western and Central Europe Eastern Europe and Central Asia Sub-Saharan Africa North Africa Middle East Asia and the Pacific

$ __________ $ __________ $ __________ $ __________ $ __________ $ __________ $ __________ $ __________ $ __________

4. In 2007, what was the intended use of your disbursed grants/projects? (Please approximate total dollar amounts as best you can for the intended use of your grants/projects. If you are unable to provide intended use data on disbursements, but could provide data based on commitments, please provide the data with a note that the data was based on commitments.) These amounts should add up to the total reported for question 1a. HIV/AIDS awareness and prevention (including harm reduction) HIV/AIDS treatment and medical care (including provider and patient treatment information) HIV/AIDS-related social services (e.g. housing, employment, food, legal) HIV/AIDS public policy, advocacy, and communications HIV/AIDS research (including medical, prevention, and social science research) Other (please specify: ____________________________________ ) *-

$ _______________________ $ _______________________ $ _______________________ $ _______________________ $ _______________________ $ _______________________ =LE;<IJ :FE:<IE<; 89FLK 8@;J

5. Target populations: Please place an ‘x’ next to the three population groups that receive the greatest benefit from your domestic and international funding. The categories below are not mutually exclusive. Please mark the three that best reflect the main target populations reached through your funding. Domestic funding People living with HIV/AIDS Women Youth Orphaned/vulnerable children (OVC) African Americans Latinos Native Americans Asians/Pacific Islanders Migrants Injecting drug users (IDU) Sex workers Health care workers Men who have sex with men (MSM) Incarcerated people Other: (_______________________)

International funding __________ __________ __________ __________ __________ __________ __________ __________ __________ __________ __________ __________ __________ __________ __________

People living with HIV/AIDS Women Youth Orphaned/vulnerable children (OVC) African Americans Latinos Native Americans Asians/Pacific Islanders Migrants Injecting drug users (IDU) Sex workers Health care workers Men who have sex with men (MSM) Incarcerated people Other: (_______________________)

__________ __________ __________ __________ __________ __________ __________ __________ __________ __________ __________ __________ __________ __________ __________

6. In-kind donations: If you would like to, please list examples of HIV/AIDS-related in-kind donations you made in 2007. ____________________________________________________________________________________________________________ ____________________________________________________________________________________________________________ ____________________________________________________________________________________________________________ 7. Re-granting: If you received $50,000 or more from any of the foundations noted in Appendix 2 in 2005, please list the value of grants received from each foundation that were subsequently re-granted through your organization. Note that your organization’s total grantmaking, including funds you re-granted, will be reflected in the FCAA report. Grant received from _________________________________________________ _________________________________________________ _________________________________________________ _________________________________________________ _________________________________________________

L % J % G ? @ C 8 E K ? I F G @ : J L G G F I K K F 8 ; ; I < J J ? @ M&8 @ ; J @ E ) ' ' .

Total re-granted to other organizations $ ___________________________________________________ $ ___________________________________________________ $ ___________________________________________________ $ ___________________________________________________ $ ___________________________________________________

JLIMCF98C I<>@FEJ

(Note: these definitions are taken from UNAIDS) Caribbean Antigua and Barbuda, Bahamas, Barbados, Cuba, Dominica, Dominican Republic, Grenada, Haiti, Jamaica, St. Kitts and Nevis, St. Lucia, St. Vincent and the Grenadines, Trinidad and Tobago Latin America Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Guyana, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Suriname, Uruguay, Venezuela Western and Central Europe Albania, Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, The former Yugoslav Republic of Macedonia, United Kingdom of Great Britain and Northern Ireland, Vatican City Eastern Europe and Central Asia Armenia, Azerbaijan, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Estonia, Georgia, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Republic of Moldova, Romania, Russian Federation, Tajikistan, Turkmenistan, Ukraine, Uzbekistan Sub-Saharan Africa Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic, Chad, Comoros, Congo, Côte d’Ivoire, Democratic Republic of Congo, Djibouti, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, Senegal, Sierra Leone, Somalia, South Africa, Swaziland, Togo, Uganda, United Republic of Tanzania Zambia, Zimbabwe North Africa Algeria, Egypt, Libyan Arab Jamahiriya, Morocco, Sudan, Tunisia Middle East Bahrain, Cyprus, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Syrian Arab Republic, Turkey, United Arab Emirates, Yemen Asia and the Pacific Afghanistan, Australia, Bangladesh, Bhutan, Brunei Darussalam, Cambodia, China, Democratic People’s Republic of Korea, Fiji, India, Indonesia, Iran (Islamic Republic of), Japan, Lao People’s Democratic Republic, Malaysia, Maldives, Mongolia, Myanmar, Nepal, New Zealand, Pakistan, Papua New Guinea, Philippines, Republic of Korea, Singapore, Sri Lanka, Thailand, Timor-Leste, Tonga, Vietnam

=LE;<IJ :FE:<IE<; 89FLK 8@;J

JLIMI8EKD8B I<$>I8EK@E> (This is the list of top 88 funders in alphabetical order, based on 2005 & 2006 data.) Abbott Laboratories Fund, IL AIDS Foundation of Chicago, IL AIDS Funding Collaborative, OH Alphawood Foundation, IL Altria Group, Inc., NY American Jewish World Service, Inc., NY The Foundation for AIDS Research (amfAR), NY The Annenberg Foundation, PA Atlanta AIDS Partnership Fund, GA The Atlantic Philanthropies, NY Avon Foundation, NY BD (Becton, Dickinson and Company), NJ Bickerstaff Family Foundation, CA Brandes Family Foundation, CA The Bristol-Myers Squibb Foundation, Inc., NY Broadway Cares/Equity Fights AIDS, NY The Susan Thompson Buffett Foundation, NE The California Endowment, CA The California Wellness Foundation, CA Campbell Foundation, FL Carnegie Corporation of New York, NY Children Affected by AIDS Foundation, CA The Children’s Investment Fund Foundation, NY Coca-Cola Africa Foundation The Comer Foundation, IL

The Community Foundation for the National Capital Region, DC Dade Community Foundation, Inc., FL The Design Industries Foundation Fighting AIDS (DIFFA), NY Irene Diamond Fund, NY Doris Duke Charitable Foundation, NY Elton John AIDS Foundation, Inc., CA ExxonMobil Foundation, TX Federated Department Stores Foundation, OH Firelight Foundation, CA The Ford Foundation, NY Bill & Melinda Gates Foundation, WA Gilead Foundation, CA The Gill Foundation, CO The Elizabeth Glaser Pediatric AIDS Foundation, CA Glaser Progress Foundation, WA The Global Fund for Women, CA Richard and Rhoda Goldman Fund, CA Evelyn and Walter Haas, Jr. Fund, CA Hartford Foundation for Public Giving, CT The Health Foundation of Greater Indianapolis, IN The William and Flora Hewlett Foundation, CA Conrad N. Hilton Foundation, NV Houston Endowment Inc., TX Indiana AIDS Fund, IN International Fund for Health & Family Planning, NY Johnson & Johnson, NJ The Robert Wood Johnson Foundation, NJ

L % J % G ? @ C 8 E K ? I F G @ : J L G G F I K K F 8 ; ; I < J J ? @ M&8 @ ; J @ E ) ' ' .

The Henry J. Kaiser Family Foundation, CA Levi Strauss Foundation, CA The John M. Lloyd Foundation, CA U U Ê -Ê Õ `Ê> `Ê U U Ê Cosmetics, NY John D. & Catherine T. MacArthur Foundation, IL The McKnight Foundation, MN The Melville Charitable Trust, MA Merck Company Foundation and Merck & Co., Inc., NJ Meyer Memorial Trust, OR Missouri Foundation for Health, MO Charles Stewart Mott Foundation, MI National AIDS Fund, DC The New York Community Trust, NY New York Foundation, NY The Overbrook Foundation, NY The David and Lucile Packard Foundation, CA The Pew Charitable Trusts, PA The Pfizer Foundation, Inc., NY The Prudential Foundation, NJ Public Welfare Foundation, Inc., DC Kate B. Reynolds Charitable Trust, NC The Robin Hood Foundation, NY Rockefeller Brothers Fund, Inc., NY The Rockefeller Foundation, NY The Saje Foundation, CA The San Francisco Foundation, CA South Africa Development Fund, MA The Starr Foundation, NY Tides Foundation, CA United Nations Foundation, DC

Until There’s A Cure Foundation, CA H. van Ameringen Foundation, NY van Ameringen Foundation, Inc., NY Washington AIDS Partnership, DC The Wells Fargo Foundation, CA W. K. Kellogg Foundation, MI

8gg\e[`o :1 Kfg L%J% ?@M&8@;J =le[\ij N\Yj`k\j

Abbott Laboratories Fund, IL

The California Endowment, CA

The Ford Foundation, NY

Indiana AIDS Fund, IN

nnn%XYYfkk%Zfd

nnn%ZXc\e[fn%fi^

nnn%]fi[]fle[%fi^

nnn%`e[`XeXX`[j]le[%fi^

AIDS Foundation of Chicago, IL

The California Wellness Foundation, CA

Bill & Melinda Gates Foundation, WA

nnn%X`[jZ_`ZX^f%fi^

nnn%kZn]%fi^

nnn%^Xk\j]fle[Xk`fe%fi^

AIDS Funding Collaborative, OH

Campbell Foundation, FL

The Gill Foundation

nnn%ZXdgY\cc]fle[Xk`fe%Zfd

nnn%^`cc]fle[Xk`fe%fi^

nnn%aea%Zfd&Zfddle`kp&`e[\o% _kd

Children Affected By AIDS Foundation, CA

Glaser Progress Foundation, WA

Henry J. Kaiser Family Foundation

nnn%ZXX]+b`[j%fi^

nnn%^cXj\igif^i\jj%fi^

nnn%b]]%fi^

Children’s Investment Fund Foundation, NY

Global Fund for Women, CA

Altria Group, Inc., NY

The W. M. Keck Foundation, CA

nnn%Xcki`X%Zfd

nnn%Z`]]%fi^

The Robert Wood Johnson Foundation, NJ nnn%ina]%fi^

Johnson & Johnson, NJ nnn%X`[j]le[`e^ZfccXYfiXk`m\% fi^

Alphawood Foundation, IL nnn%Xcg_Xnff[]fle[Xk`fe%Zfd

nnn%^cfYXc]le[]finfd\e%fi^

nnn%ndb\Zb%fi^

The Comer Foundation, IL

The George Gund Foundation, OH

W.K. Kellogg Foundation, MI

nnn%Zfd\i$]fle[Xk`fe%Zfd

nnn%^le[][e%fi^

nnn%nbb]%fi^

The Design Industries Foundation Fighting AIDS (DIFFA), NY

Hartford Foundation of Public Giving, CT

The Kresge Foundation, MI

The Foundation for AIDS Research (amfAR), NY nnn%Xd]Xi%fi^

nnn%[`]]X%fi^

American Jewish World Service, Inc., NY nnn%Xanj%fi^

nnn%bi\j^\%fi^

nnn%_]g^%fi^

Levi Strauss Foundation, CA nnn%c\m`jkiXljj%Zfd&Z`k`q\ej_`g

The Annenberg Foundation, PA

Doris Duke Charitable Foundation, NY

The Health Foundation of Greater Indianapolis, Inc., IN

nnn%Xee\eY\i^]fle[Xk`fe%fi^

nnn%[[Z]%fi^

nnn%k_]^`%Zfd

nnn%af_edccfp[%fi^

Atlanta AIDS Partnership Fund, GA

Elizabeth Glaser Pediatric AIDS Foundation, CA

The Healthcare Foundation of New Jersey, NJ

U U Ê -Ê Õ `Ê> `Ê U U Ê Ã iÌ VÃ]Ê 9

nnn%X`[j]le[Xkc%fi^

nnn%g\[X`[j%fi^

nnn%_]ea%fi^

nnn%dXZX`[j]le[%fi^

BD (Becton, Dickinson and Company), NJ

Elton John AIDS Foundation, Inc., CA

The William and Flora Hewlett Foundation, CA

John D. & Catherine T. MacArthur Foundation, IL

nnn%Y[%Zfd&i\jgfej`Y`c`kp

nnn%\aX]%fi^

nnn%_\nc\kk%fi^

nnn%dXZ]fle[%fi^

Bristol-Myers Squibb Foundation, Inc., NY

ExxonMobil Foundation, TX

HIV Collaborative Fund, a project of the Tides Center, CA

The Merck Company Foundation, NJ

nnn%Ydj%Zfd

nnn%\oofedfY`c%Zfd& Zfddle`kp

John M. Lloyd Foundation, CA

nnn%d\iZb%Zfd&Zi

nnn%_`mZfccXYfiXk`m\]le[%fi^

Broadway Cares/Equity Fights AIDS, NY nnn%YifX[nXpZXi\j%fi^

Firelight Foundation, CA nnn%Ôi\c`^_k]fle[Xk`fe%fi^

Houston Endowment Inc., TX

Missouri Foundation for Health, MO

nnn%_fljkfe\e[fnd\ek%fi^

nnn%d]]_%fi^

=LE;<IJ :FE:<IE<; 89FLK 8@;J

National AIDS Fund, DC nnn%X`[j]le[%fi^

The New York Community Trust, NY nnn%epZfddle`kpkiljk%fi^

The Rockefeller Foundation, NY

Washington AIDS Partnership, DC

nnn%ifZb]fle[%fi^

nnn%nXj_`e^kfeX`[jgXike\ij_`g% fi^

San Francisco AIDS Foundation, CA nnn%j]X]%fi^

The John R. Oishei Foundation, NY nnn%f`j_\`][k%fi^

The San Francisco Foundation, CA nnn%j]]%fi^

The David & Lucille Packard Foundation, CA nnn%gXZbXi[%fi^

The Pew Charitable Trusts, PA The Starr Foundation, NY nnn%jkXii]fle[Xk`fe%fi^

The Pfizer Foundation, NY nnn%gÔq\ig_`cXek_ifgp%Zfd

nnn%n\ccj]Xi^f%Zfd&XYflk& Z_Xi`kXYc\

Williamsburg Community Health Foundation, VA nnn%nZ_]%Zfd

Silicon Valley Community Foundation, CA nnn%j`c`ZfemXcc\pZ]%fi^

nnn%g\nkiljkj%Zfd

Wells Fargo Foundation, CA

Staying Alive Foundation, NY nnn%jkXp`e^$Xc`m\%fi^&\e&_fd\

Polk Bros. Foundation, IL nnn%gfcbYifj][e%fi^

South Africa Development Fund

Public Welfare Foundation Inc., DC

nnn%jflk_X]i`ZX$e\npfib%e\k& jX[]%_kd

Note: The Bickerstaff Family Foundation, the International Fund for Health and Family Planning, the Irene Diamond Fund, the James B. Pendleton Charitable Trust, the San Diego HIV Funding Collaborative, the H. van Ameringen Foundation, and the White Flowers Foundation do not have Web sites.

nnn%glYc`Zn\c]Xi\%fi^

Tides Foundation, CA Kate B. Reynolds Charitable Trust, NC

nnn%k`[\j%fi^

nnn%bYi%fi^

United Nations Foundation, DC

Richmond County Savings Foundation, NY

nnn%le]fle[Xk`fe%fi^

nnn%iZj]%fi^&iZj]&`e[\o%Xjg

United Way of New York City, NY

Robin Hood Foundation, NY

nnn%le`k\[nXpepZ%fi^

nnn%ifY`e_ff[%fi^

Rockefeller Brothers Fund, Inc., NY

Until There’s a Cure Foundation, CA nnn%lek`c%fi^

nnn%iY]%fi^

L % J % G ? @ C 8 E K ? I F G @ : J L G G F I K K F 8 ; ; I < J J ? @ M&8 @ ; J @ E ) ' ' .

8gg\e[`o ;1 Gi\c`d`eXip C`jk f] >cfYXc ?@M&8@;J =le[\ij

The Working Group on Global Philanthropic Resource Tracking (FCAA, EFG, and UNAIDS) is in the process of developing a comprehensive global list of funders providing support for the response to HIV/AIDS. Below is an initial, preliminary list of the private funders outside of European Union countries and the United States we have been able to identify to date. We encourage other funders involved in HIV/AIDS philanthropy to contact us at info@fcaaids.org so we can include you in our forthcoming global publication. 8I><EK@E8

Fundacion Coinsida, Buenos Aires Fundacion Mantovano Para La Prevencion Del Sida Y Drogadiccion, Buenos Aires www.drwebsa.com.ar/fmsida/ index.htm Fundacion Minoridad En Riesgo Padre Jorge Herrera Gallo, Buenos Aires Fundacion Para La Promocion De La Salud Humana, Cordoba Fundacion Red, Buenos Aires www.redsida.org.ar Fundacion Renacer, Santa Fe www.fundacionrenacer.org Proyecto Nombres Argentina, Buenos Aires +)

8LJKI8C@8

Bobby Goldsmith Foundation, Sydney www.bgf.org.au Buoyancy Foundation Of Victoria, Richmond home.vicnet.net.au/~buoyancy The Quilt Project Sydney, Darlinghurst www.aidsquilt.org.au The Helen Macpherson Smith Trust www.hmstrust.org.au

Stephen Lewis Foundation www.stephenlewisfoundation. org Rooftops Canada Foundation Inc.- Fondation Abri International www.rooftops.ca Dr. Peter AIDS Foundation www.drpeter.org AIDS Foundation of Canada www.aidsfoundation.ca Snowy Owl AIDS Foundation www.snowyowl.org

Helen Neuborne Trust

:FCFD9@8

Fundacion Colombiana De Apoyo En SIDA, Hepatitis Y Enferm. De Transmision Sexual Fundacion Grupo Gales Colombia, Santafe De Bogota www.grupogales.com <C J8CM8;FI

Fundacion Nacional Para La Prevencion Educacion Y Acompanamiento De La Person VIH/SIDA, San Salvador

Worldwide AIDS Foundation

Fundacion Salvadorena Antidrogas, San Salvador www.fundasalva.org.sv

The Allan Vincent Smith Foundation, Hamilton www.avsf.bm

AIDS Committee Of London West Africa AIDS Foundation www.aidslondon.com/waaf.asp

>?8E8

9I8Q@C

Match International www.matchinternational.org

9<IDL;8

Fundacao Athos Bulcao, Brasilia www.fundathos.org.br :8E8;8

Canadian Foundation For AIDS Research (CANFAR) www.canfar.com The Farha Foundation, Montreal www.farha.qc.ca/en/index.html

African Women’s Development Fund www.awdf.org >L8K<D8C8

:?@E8# G<FGC<ËJ I<GL9C@: F= :?@E8

Chi Heng Foundation, Hong Kong www.chihengfoundation.com The Hong Kong AIDS Foundation www.aids.org.hk

Fundacion Preventiva Del SIDA Fernando Iturbide, Guatemala City @E;@8

Rajiv Gandhi Foundation, New Delhi www.rgfindia.com TEST Foundation, Chennai

K8@N8E

Fife House Foundation, Toronto www.fifehouse.org

The Garden Of Hope Foundation, Taipei www.goh.org.tw/english

Integration Society

The Lazarus Foundation, Regina

Nurses’ AIDS Prevention Foundation, Taipei

Naz Foundation www.nazindia.org

Sukriti Foundation

=LE;<IJ :FE:<IE<; 89FLK 8@;J

Vasavya Mahila Mandali (VMM) www.vasavya.com MAMTA Health Institute For Mother And Child (MAMTA) ww.mamta-himc.org Palmyrah Workers Development Society (PWDS) www.pwds.org LEPRA Society www.leprasociety.org Humsafar Trust www.humsafar.org Indian Network Of Positive People www.inpplus.net

AFI;8E

Noor Al-Hussein Foundation, Amman www.nooralhusseinfoundation. org

G8E8D8 B<EP8

Fundacion PRIDE De Panama

Christian Children’s Fund, Inc.-Kenya

G?@C@GG@E<J

Allavida www.allavida.org

Women’s Media Circle Foundation, Inc. www.womensmedia-manila.org

AMREF Kenya kenya.amref.org BPI>PQJK8E

Soros Foundation – Kyrgyzstan www.soros.org/about/ foundations/kyrgyzstan D<O@:F

Sangram www.sangram.org North East India Harm Reduction Network The Nand & Jeet Khemka Foundation www.khemkafoundation.org

Fundacion Mexicana Para La Lucha Contra El SIDA, A.C. www.sidamexico.org Fundacion Nemi www.nemi.com.mx DFQ8D9@HL<

@JI8<C

Foundation For Community Development www.fdc.org.mz

The Jerusalem Foundation www.jerusalemfoundation.org

E<N Q<8C8E;

A8G8E

J.R. Mckenzie Trust www.jrmckenzie.org.nz

Japanese Foundation For AIDS Prevention, Tokyo www.jfap.or.jp/english/index. htm

The Youngstars Foundation, Dadin Kowa www.youngstarsfoundation. org/NGR

New Zealand AIDS Foundation www.nzaf.org.nz Te Whare Awhina Foundation

Vodacom www.vodacom.co.za South African AIDS Foundation www.aids.org.za Ikhala Trust www.ikhala.org.za Coxswain Social Investment Plus www.coxsi.com

GFC8E;

Foundation For Corporate Responsibility www.Fcsr.Pl/Fcsr_Eng_ Nasipartnerzy_.Html J@<II8 C<FE<

The Alpha Foundation Of Sierra Leone www.alphafoundation.org JFLK? 8=I@:8

Open Society Foundation For South Africa, Newlands www.osf.org.za Atlantic Philanthropies, South Africa Office Nelson Mandela Foundation www.nelsonmandela.org Nelson Mandela Children’s Fund www.nmcf.co.za

Dockda Rural Development Agency Uthungulu Community Foundation www.ucf.org.za L>8E;8

The African Child Foundation, Namansuba-Ndeije Village groups.msn.com/ africanchildfoundation African Medical And Research Foundation (Uganda), Kampala www.amref.org Q8D9@8

Faith Orphanage Foundation, Kitwe www.geocities.com/fofsao/ homepage Q@D989N<

Starfish www.starfishcharity.org Anglo American www.angloamerican.co.uk

Community Foundation For The Western Region Of Zimbabwe www.westfound.com

E@><I@8

The Lazarus Foundation, Benin City L % J % G ? @ C 8 E K ? I F G @ : J L G G F I K K F 8 ; ; I < J J ? @ M&8 @ ; J @ E ) ' ' .

8Zbefnc\[^\d\ekj

=:88 9F8I; F= ;@I<:KFIJ

John Barnes YifX[nXp ZXi\j&\hl`kp ]`^_kj X`[j

Patricia Doykos Duquette Yi`jkfc$d\p\ij jhl`YY ]fle[Xk`fe# `eZ%

FCAA staff and consultants involved in the research and writing of this publication include: Sunita Viswanath (formerly Mehta) \o\Zlk`m\ [`i\Zkfi

Kandy S. Ferree eXk`feXc X`[j ]le[

Bob Bronzo gif^iXd dXeX^\i

Desiree Flores Z_X`i dj% ]fle[Xk`fe ]fi nfd\e

Sarah Hamilton [\m\cfgd\ek Zfddle`ZXk`fej dXeX^\i

© December 2008, Funders Concerned About AIDS Brooklyn, NY. Permission is granted to reproduce this document in part or in its entirety, provided that Funders Concerned About AIDS (FCAA) is cited as the source for all reproduced material. This document is posted and distributed primarily as an electronic condensed PDF file. Please feel free to contact FCAA if you would prefer printed copies of this report.

Anu Gupta af_ejfe af_ejfe

Rebecca Andruszka

Melanie Havelin

]fid\i [\m\cfgd\ek Zfddle`ZXk`fej dXeX^\i

k_\ af_e d% ccfp[ ]fle[Xk`fe

Ann Maldonado Mia Herndon

X[d`e`jkiXk`m\ Zffi[`eXkfi

k_`i[ nXm\ ]fle[Xk`fe

Rachel Giuliani Mark Ishaug

gif^iXd Xjj`jkXek

X`[j ]fle[Xk`fe f] Z_`ZX^f

Esmeralda Perez Jennifer Kates

`ek\ie

k_\ _\eip a% bX`j\i ]Xd`cp ]fle[Xk`fe

Chris Collins and Erika Baehr LaTida Lester

ZfejlckXekj

jX`ek clb\Ëj ]fle[Xk`fe f] Zc\m\cXe[# f_`f

Jasmine Thomas k_\ e\n pfib Zfddle`kp kiljk

Design158 [\j`^e

189 Montague Street Suite 801A Brooklyn, NY 11201 Telephone: 718.875.0251 Fax: 718.875.0255 E-mail: info@fcaaids.org Web site: www.fcaaids.org ++

=LE;<IJ :FE:<IE<; 89FLK 8@;J

=LE :FE 89F